A substance (or active part thereof) that kills or slows the growth of bacteria.
| Member | Definition | Class |
|---|
| (+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside | A lignan that is (+)-lyoniresinol substituted by a beta-D-glucopyranosyl moiety at position 3 via a glycosidic linkage. Isolated from the root barks of Stemmadenia minima and Lycium chinense, it exhibits antimicrobial activities. | (+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside |
| 1-hexanol | A primary alcohol that is hexane substituted by a hydroxy group at position 1. | hexan-1-ol |
| 2-hexenal, z-isomer | A 2-hexenal in which the olefinic double bond has E configuration. It occurs naturally in a wide range of fruits, vegetables, and spices. | (2E)-hexenal |
| 2-n-octyl-4-isothiazolin-3-one | A member of the class of 1,2-thiazole that is 1,2-thiazol-3-one substituted on the nitrogen (position 2) by an octyl group. A fungicide and antibacterial agent, it is used for treatment of canker and other fungal and bacterial diseases in fruit trees. It is no longer approved for use within the European Union. | octhilinone |
| 3-phenylbutyric acid | A monocarboxylic acid that is butanoic acid substituted by a phenyl group at position 3. | 3-phenylbutyric acid |
| 3,3'-di-o-methylquercetin | A dimethoxyflavone that is quercetin in which the hydroxy groups at position 3 and 3' have been replaced by methoxy groups. It has been isolated from several plant species and exhibits anti-bacterial and anti-cancer properties. | 3,3'-dimethylquercetin |
| 3,6-diamino-10-methylacridinium chloride hydrochloride | A hydrochloride resulting from the reaction of equimolar amounts of 3,6-diamino-10-methylacridinium chloride and hydrogen chloride. | 3,6-diamino-10-methylacridinium chloride.HCl |
| 4-hydroxycordoin | A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at position 4 and 2' and a (3-methylbut-2-en-1-yl)oxy group at position 4'. It has been isolated from Lonchocarpus neuroscapha. | 4-hydroxycordoin |
| 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol | A terpineol that is 1-menthene carrying a hydroxy substituent at position 4. | 4-terpineol |
| 5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine | A member of the class of thiadiazoles that is 1,3,4-thiadiazol-2-amine which is substituted by a (5-nitro-1,3-thiazol-2-yl)sulfanediyl group at position 5. It is a c-Jun N-terminal kinase inhibitor (IC50 = 0.7uM) and exhibits antibacterial properties. | halicin |
| 5-methoxyindoleacetic acid | A member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group. | 5-methoxyindole-3-acetic acid |
| 5-o-methyllicoricidin | A member of the class of hydroxyisoflavans that is the 7-O-methyl derivative of licoricidin. Isolated from Glycyrrhiza uralensis, it exhibits antibacterial activity. | licorisoflavan A |
| 5,4'-dihydroxy-7,3'-dimethoxyflavone | A dimethoxyflavone that is luteolin in which the hydroxy groups at positions 7 and 3' are replaced by methoxy groups. | velutin |
| 6-methoxybenzoxazolinone | A 2-benzoxazolinone that is substituted by a methoxy group at position 6. | 6-methoxy-2-benzoxazolinone; Coixol |
| 6-tuliposide b | A 6-O-acyl-D-glucose in which the 6-acyl group is specified as (3S)-3,4-dihydroxy-2-methylidenebutanoyl. A secondary metabolite with potent antibacterial activity, occurring specifically in tulip anthers. | 6-tuliposide B |
| 6,8-diprenylgenistein | A member of the class of 7-hydroxyisoflavones that is genistein substituted by prenyl groups at positions 6 and 8. It has been isolated from Derris scandens and Glycyrrhiza uralensis. | 5,7,4'-trihydroxy-6,8-diprenylisoflavone |
| 7-aminocholesterol | A 3beta-sterol that is cholesterol substituted at position 7 by an amino group. | 7-aminocholesterol |
| acetopyrrothine | A dithiolopyrrolone antibiotic that is 4,5-dihydro[1,2]dithiolo[4,3-b]pyrrole in which the hydrogens at positions 4,5 and 6 have been replaced by methyl, oxo and acetamido groups, respectively. It is a potent inhibitor of RNA polymerases, inhibits the angiogenesis of human umbilical vein endothelial cells, and also inhibits JAMM metalloproteases. | thiolutin |
| acriflavine chloride | The 10-methochloride salt of 3,6-diaminoacridine. Note that a mixture of this compound with 3,6-diaminoacridine (proflavine) is known as acriflavine or neutral acriflavine. | 3,6-diamino-10-methylacridinium chloride |
| acteoside | A glycoside that is the alpha-L-rhamnosyl-(1->3)-beta-D-glucoside of hydroxytyrosol in which the hydroxy group at position 4 of the glucopyranosyl moiety has undergone esterification by formal condensation with trans-caffeic acid. | acteoside |
| actinodaphine | An organic heteropentacyclic compound 6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline bering additional hydroxy and methoxy substituents at positions 10 and 11 respectively. | actinodaphnine |
| alexidine | An amphipathic bisbiguanide with a structure consisting of two (2-ethylhexyl)guanide units linked by a hexamethylene bridge. | alexidine |
| allicin | | allicin |
| allyl alcohol | A propenol in which the C=C bond connects C-2 and C-3. It is has been found in garlic (Allium sativum). Formerly used as a herbicide for the control of various grass and weed seeds. | allyl alcohol |
| althiomycin | A peptide antibiotic isolated from soil and enteric bacteria. It is a protein synthesis inhibitor which exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria. | althiomycin |
| anacardic acid | A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities. | anacardic acid |
| apigetrin | A glycosyloxyflavone that is apigenin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | apigenin 7-O-beta-D-glucoside |
| arbekacin | A kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring. | arbekacin |
| arjunolic acid | A pentacyclic triterpenoid that is olean-12-en-28-oic acid substituted by hydroxy groups at positions 2, 3 and 23 (the 2alpha,3beta stereoisomer). Isolated from Symplocos lancifolia and Juglans sinensis, it exhibits antioxidant and antimicrobial activities. | arjunolic acid |
| asukamycin | A polyketide that is a member of the manumycin family of antibiotics and exhibits strong antibacterial, antifungal, and antineoplastic activities. Isolated from from the actinomycete bacterium Streptomyces nodosus subsp. asukaensis. | asukamycin |
| atromentin | A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxycyclohexa-2,5-diene-1,4-dione which is substituted by a 4-hydroxyphenyl group at positions 3 and 6. It is a mushroom pigment isolated from several fungi species and acts as a smooth muscle stimulant, and exhibits anticoagulant, antibacterial and antineoplastic properties. | atromentin |
| aurachin a | An A-type aurichin that is 1,2-dihydrofuro[2,3-c]quinoline 5-oxide which is substituted at position 2 by a (6E)-10-hydroxy-2,6-dimethylundeca-2,6-dien-10-yl group and at position 4 by a methyl group (relative configuration shown). Found in the myxobacterium Stigmatella aurantiaca strain Sg a15. | aurachin A |
| aurachin c | A C-type aurachin that is quinolin-4-one which is substituted by a hydroxy group at positions 1, a methyl group at position 2, and a triprenyl group at position 3. | aurachin C |
| aureothin | A C-nitro compound that is (3Z)-3-[(2E)-2-methyl-3-(4-nitrophenyl)prop-2-en-1-ylidene]tetrahydrofuran which is substituted by a 6-methoxy-3,5-dimethyl-4-oxo-4H-pyran-2-yl group at position 5. It is isolated from the soil bacterium, Streptomyces thioluteus and exhibits antitumor, antifungal, and insecticidal activities. | aureothin |
| aureothricin | A dithiolopyrrolone antibiotic that is 4,5-dihydro[1,2]dithiolo[4,3-b]pyrrole in which the hydrogens at positions 4,5 and 6 have been replaced by methyl, oxo and propanoylamino groups, respectively. It is a moderate antimicrobial by-product of the thiolutin fermentation in various Streptomyces species. | aureothricin |
| azelaic acid | An alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. | nonanedioic acid |
| baci-im | A homodetic cyclic peptide consisting of (4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid attached head-to-tail to L-leucyl,D-glutamyl, L-lysyl, D-ornityl, L-isoleucyl, D-phenylalanyl, L-histidyl. D-aspartyl and L-asparaginyl residues coupled in sequence and cyclised by condensation of the side-chain amino group of the L-lysyl residue with the C-terminal carboxylic acid group. It is the major component of bacitracin. | bacitracin A zwitterion; bacitracin A |
| bacillaene | A polyene antibiotic obtained from Bacillus subtilis 168 that is active against a broad spectrum of bacteria. It is notoriously unstable. | bacillaene |
| baicalein | A trihydroxyflavone with the hydroxy groups at positions C-5, -6 and -7. | baicalein |
| baicalin | The glycosyloxyflavone which is the 7-O-glucuronide of baicalein. It is an active ingredient of Chinese herbal medicine Scutellaria baicalensis. | baicalin |
| bay 11-7085 | A sulfone that is benzene substituted by [(E)-2-cyanoethenyl]sulfonyl and tert-butyl groups at position 1 and 4, respectively. It is an irreversible inhibitor of IkappaB-alpha phosphorylation in cells (IC50 = 10 muM) and prevents the activation of NF-kappaB. | BAY11-7085 |
| benzethonium chloride | A (synthetic) quaternary ammonium salt that is benzyldimethylamine in which the nitrogen is quaternised by a 2-{2-[p-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethyl group, with chloride as the counter-ion. An antiseptic and disinfectant, it is active against a broad spectrum of bacteria, fungi, moulds and viruses. | benzethonium chloride |
| beta-thujaplicin | A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities. | beta-thujaplicin |
| bicozamycin | A commercially important azabicyclic antibiotic obtained from Streptomyces sapporonensis. It inhibits the Rho protein of E. coli. | bicozamycin |
| boromycin | A boron-containing macrolide antibiotic that is isolated from Streptomyces antibioticus. | boromycin |
| brazilin | A organic heterotetracyclic compound that is a red pigment obtained from the wood of Caesalpinia echinata (Brazil-wood) or Caesalpinia sappan (sappan-wood). | brazilin |
| brilliant green | An organic hydrogensulfate salt having 4-{[4-(diethylamino)phenyl](phenyl)methylidene}-N,N-diethylcyclohexa-2,5-dien-1-iminium as the counterion. | brilliant green |
| bromodeoxytopsentin | An aromatic ketone that is imidazole which is substituted by a 1H-indole-3-carbonyl group and a 6-bromo-1H-indol-3-yl group at positions 2 and 4, respectively. Isolated from the Mediterranean shallow-water sponge, Topsentia genetrix. It is a potent inhibitor of MRSA pyruvate kinase and exhibits antibacterial properties. | bromodeoxytopsentin |
| bromophycolide a | A diterpenoid that is a macrolide isolated from the Fijian red alga Callophycus serratus. It has been found to exhibit moderate cytotoxicity against several human tumour cell lines via specific apotopic cell death. It also displays anti-HIV, antibacterial, antifungal and antimalarial activity. | bromophycolide A |
| caffeic acid phenethyl ester | An alkyl caffeate ester in which 2-phenylethyl is the alkyl component. | phenethyl caffeate |
| cannabigerol | A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. | cannabigerol |
| carbonyl cyanide m-chlorophenyl hydrazone | A member of the class of monochlorobenzenes that is benzene substituted by 2-(1,3-dinitrilopropan-2-ylidene)hydrazinyl and chloro groups at positions 1 and 3, respectively. It is a mitochondrial depolarizing agent that induces reactive oxygen species mediated cell death. | CCCP |
| chelerythrine | A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae. | chelerythrine |
| chlorhexidine | A bisbiguanide compound with a structure consisting of two (p-chlorophenyl)guanide units linked by a hexamethylene bridge. | chlorhexidine |
| chlorhexidine | A bisbiguanide compound with a structure consisting of two (p-chlorophenyl)guanide units linked by a hexamethylene bridge. | chlorhexidine |
| chloroxine | A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 have been substituted by chlorine. A synthetic antibacterial prepared by chlorination of quinolin-8-ol, it is used for the treatment of dandruff and seborrhoeic dermatitis of the scalp. | chloroxine |
| cholesteryl arachidonate | A cholesterol ester obtained by the formal condensation of the hydroxy group in cholesterol with the carboxy group of arachidonic acid. | cholesteryl arachidonate |
| chuangxinmycin | A thiinoindole that is 3,5-dihydro-2H-thiino[4,3,2-cd]indole which is substituted at positions 2 and 3 by carboxy and methyl groups, respectively (the 2R,3S diastereoisomer). | (-)-chuangxinmycin |
| ciclopirox | A cyclic hydroxamic acid that is 1-hydroxypyridin-2(1H)-one in which the hydrogens at positions 4 and 6 are substituted by methyl and cyclohexyl groups, respectively. A broad spectrum antigfungal agent, it also exhibits antibacterial activity against many Gram-positive and Gram-negative bacteria, and has anti-inflammatory properties. It is used a a topical treatment of fungal skin and nail infections. | ciclopirox |
| clioquinol | A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease. | 5-chloro-7-iodoquinolin-8-ol |
| cloflucarban | A phenylurea that is urea substituted by 4-chlorophenyl and 4-chloro-3-trifluoromethylphenyl groups at positions 1 and 3 respectively. It is often used in deodarants and soaps on account of its anbacterial properties. | halocarban |
| cloxacillin | A semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6. | cloxacillin |
| conessine | A steroid alkaloid that is con-5-enine substituted by a N,N-dimethylamino group at position 3. It has been isolated from the plant species of the family Apocynaceae. | conessine |
| cudraflavone c | A tetrahydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 7, 2' and 4' and prenyl groups at positions 3 and 6. Isolated from Morus nigra, it exhibits antibacterial and cytotoxic activities. | cudraflavone C |
| cytotrienin a | A 21-membered macrocyclic lactam which contains three conjugated double bonds as part of the ring system. It acts as an apoptosis inducer in human leukemia HL-60 cells and is isolated from Streptomyces sp. | cytotrienin A |
| dazomet | A dithiocarbamic ester that is 1,3,5-thiadiazinane with a thione moiety at position 2 and in which the hydrogens attached to the nitrogens are replaced by methyl groups. A fungicide, herbicide and nematicide, it is used prior to sowing or planting for the control of soil fungi, nematodes, bacteria and germinating weeds, and as fumigant for poultry litter and eggs to control Salmonella. It is a non-ozone-depleting alternative to methyl bromide. | dazomet |
| decanoic acid | A C10, straight-chain saturated fatty acid. | decanoic acid |
| dehydroacetic acid | A pyran-2,4-dione substituted at position 3 by an acetyl group and at position 6 by a methyl group. A fungicide and bactericide it is used primarily in processed fruit and vegetables. | dehydroacetic acid |
| diazooxonorleucine | A non-proteinogenic L-alpha-amino acid that is L-norleucine which is substituted at position 5 by an oxo group and at position 6 by a diazo group. It is as inhibitor of various glutamine-utilising enzymes. | 6-diazo-5-oxo-L-norleucine zwitterion; 6-diazo-5-oxo-L-norleucine |
| dibekacin | A kanamycin that is kanamycin B lacking the 3- and 4-hydroxy groups on the 2,6-diaminosugar ring. | dibekacin |
| dichlorvos | An alkenyl phosphate that is the 2,2-dichloroethenyl ester of dimethyl phosphate. | dichlorvos |
| dicranin | A trienoic fatty acid, that is octadecanoic acid containing double bonds at positions 9, 12 and 15 and a triple bond at position 6. Isolated from Dicranum scoparium, it exhibits antibacterial activity and inhibitory activity against arachidonate 15-lipoxygenase. | (9Z,12Z,15Z)-octadeca-9,12,15-trien-6-ynoic acid |
| diversonol | | (+)-diversonol |
| dodine | An acetate salt resulting from the reaction of equimolar amounts of 1-dodecylguanidine and acetic acid. It is used as a fungicide to control black spot and foliar diseases on apples, pears, peaches, nectarines and strawberries. | 1-dodecylguanidine acetate |
| ebselen | A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase. | ebselen |
| enrofloxacin | A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid substituted by an oxo group at position 4, a fluoro group at position 6, a cyclopropyl group at position 1 and a 4-ethylpiperazin-1-yl group at position 7. It is a veterinary antibacterial agent used for the treatment of pets. | enrofloxacin |
| entrectinib | A member of the class of indazoles that is 1H-indazole substituted by [4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzoyl]amino and 3,5-difluorobenzyl groups at positions 3 and 5, respectively. It is a potent inhibitor of TRKA, TRKB, TRKC, ROS1, and ALK (IC50 values of 0.1 to 1.7 nM), and used for the treatment of NTRK, ROS1 and ALK gene fusion-positive solid tumours. | entrectinib |
| epidermin | A type A lantibiotic that is a tetracyclic 21-amino-acid peptide which contains meso-lanthionine, 3-methyllanthionine, and S-(2-aminovinyl)-D-cysteine. It is obtained from Staphylococcus epidermidis Tue 3298 and exhibits antibiotic activity against many Gram-positive bacteria. | epidermin |
| equisetin | A member of the class of tetramic acids that is trichosetin in which the hydrogen attached to the lactam nitrogen has been replaced by a methyl group. It is produced by the filamentous fungus Fusarium heterosporum. | equisetin |
| ethyl acetoacetate | An ethyl ester resulting from the formal condensation of the carboxy group of acetoacetic acid with ethanol. | ethyl acetoacetate |
| ethyl protocatechuate | An ethyl ester resulting from the formal condensation of the carboxy group of 3,4-dihydroxybenzoic acid with ethanol. It is the anti-oxidative component of peanut seed testa. | ethyl 3,4-dihydroxybenzoate |
| etimicin | An aminoglycoside antibiotic that is gentamycin C1a in which the hydrogen of the amino group at position 1 is substituted by an ethyl group. It is a fourth generation semisynthetic aminoglycoside that has antimicrobial activity against both gram-positive and gram-negative bacterial infections and also effective against aminoglycoside resistant strains. | etimicin |
| etnangien | A macrolide antibiotic isolated from the culture broth of the myxobacterium Sorangium cellulosum and has been found to be active against Gram-positive bacteria. | etnangien |
| ferruginol | An abietane diterpenoid that is abieta-8,11,13-triene substituted by a hydroxy group at positions 12. | ferruginol |
| fonsecinone a | A dimeric naphthopyran with formula C32H26O10, originally isolated from Aspergillus niger. | fonsecinone A |
| formic acid | The simplest carboxylic acid, containing a single carbon. Occurs naturally in various sources including the venom of bee and ant stings, and is a useful organic synthetic reagent. Principally used as a preservative and antibacterial agent in livestock feed. Induces severe metabolic acidosis and ocular injury in human subjects. | formic acid |
| fortimicin a | An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. | astromicin |
| fr 148083 | A macrolide that is the 7-oxo derivative of zeaenol (the 5Z stereoisomer). Isolated from Fungi, it exhibits cytotoxic, antibacterial and inhibitory activity against NF-kappaB. | 5Z-7-oxozeaenol |
| fraxetin | A hydroxycoumarin that is 6-methoxycoumarin in which the hydrogens at positions 7 and 8 have been replaced by hydroxy groups. | fraxetin |
| fumimycin | A member of the class of 1-benzofurans that is 1-benzofuran-2(3H)-one substituted by a propenyl group at position 4, hydroxy groups at positions 5 and 6, methyl group at position 3 and a [(2E)-3-carboxyprop-2-enoyl]nitrilo group at position 3. Isolated from the fermentation broth of Aspergillus fumisynnematus F746, it exhibits antibacterial activity. | fumimycin |
| furanomycin | A non-proteinogenic L-alpha-amino acid that is L-alanine in which the methyl group is replaced by a (2R,5S)-5-methyl-2,5-dihydrofuran-2-yl moiety. | furanomycin |
| gancaonin I | A member of the class of 1-benzofurans which consists of 1-benzofuran substituted by methoxy groups at positions 4 and 6, a prenyl group at position 5 and a 2,4-dihydroxyphenyl group at position 2. It has been isolated from Glycyrrhiza uralensis. | gancaonin I |
| gentian violet | An iminium ion that is malachite green cation in which the hydrogen at the para- psition of the monosubstituted phenyl group is replaced by a dimethylamino group. | crystal violet cation |
| gentian violet | An organic chloride salt that is the monochloride salt of crystal violet cation. It has been used in creams for the topical treatment of bacterial and fungal infections, being effective against some Gram-positive bacteria (notably Staphylococcus species) and some pathogenic fungi (including Candida species) but use declined following reports of animal carcinogenicity. It has also been used for dying wood, silk, and paper, as well as a histological stain. | crystal violet |
| glaucine | An aporphine alkaloid that is (S)-1,2,9,10-tetrahydroxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline in which the four phenolic hydrogens have been replaced by methyl groups. | (S)-glaucine |
| glycyrin | A member of the class of coumarins that is coumarin substituted by methoxy groups at positions 5 and 7, a prenyl group at position 6 and a 2,4-dihydroxyphenyl group at position 3. Isolated from Glycyrrhiza uralensis, it exhibits antibacterial activity. | glycyrin |
| gramine | An aminoalkylindole that is indole carrying a dimethylaminomethyl substituent at postion 3. | gramine |
| griseofulvin | An oxaspiro compound produced by Penicillium griseofulvum. It is used by mouth as an antifungal drug for infections involving the scalp, hair, nails and skin that do not respond to topical treatment. | griseofulvin |
| helvolic acid | A steroid C-21 acid having a 29-nordammarane skeleton substituted with an acetoxy group at C-16 and oxo groups at C-3 and -7, with double bonds at C-1, -17(20) and -24. | helvolic acid |
| heptachlor | A cyclodiene organochlorine insecticide that is 3a,4,7,7a-tetrahydro-1H-4,7-methanoindene substituted by chlorine atoms at positions 1, 4, 5, 6, 7, 8 and 8. Formerly used to kill termites, ants and other insects in agricultural and domestic situations. | heptachlor |
| hexachlorophene | An organochlorine compound that is diphenylmethane in which each of the phenyl groups is substituted by chlorines at positions 2, 3, and 5, and by a hydroxy group at position 6. An antiseptic that is effective against Gram-positive organisms, it is used in soaps and creams for the treatment of various skin disorders. It is also used in agriculture as an acaricide and fungicide, but is not approved for such use within the European Union. | hexachlorophene |
| holomycin | A dithiolopyrrolone antibiotic that is 4,5-dihydro[1,2]dithiolo[4,3-b]pyrrole in which the hydrogens at positions 5 and 6 have been replaced by oxo and acetamido groups, respectively. It is an inhibitor of DNA-dependent RNA polymerase, and exhibits antibacterial and antitumour properties. | holomycin |
| hypothiocyanite ion | A sulfur oxoacid that is sulfenic acid in which the hydrogen attached to the sulfur has been replaced by a cyano group. | hypothiocyanous acid |
| ilomastat | An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor | ilomastat |
| indolmycin | A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted at the 2 and 5-pro-S positions by methylamino and [(1R)-1-(1H-indol-3-yl)ethyl] groups, respectively. | indolmycin |
| iodoquinol | A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by iodine. It is considered the drug of choice for treating asymptomatic or moderate forms of amoebiasis. | iodoquinol |
| isobavachalcone | A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2' and 4' and a prenyl group at position 3'. | isobavachalcone |
| isovanillic acid | A methoxybenzoic acid that is 4-methoxybenzoic acid bearing a hydroxy substituent at position 3. | 3-hydroxy-4-methoxybenzoic acid |
| jadomycin b | A jadomycin that is jadomycin A in which the phenolic hydroxy group at position 12 has been converted to the corresponding 2,6-dideoxy-alpha-L-ribo-hexopyranoside, isolated from Streptomyces venezuelae. It exists as a diastereoisomeric mixture consisting of both 3aS and 3aR isomers. | jadomycin B |
| kaempferol | A tetrahydroxyflavone in which the four hydroxy groups are located at positions 3, 5, 7 and 4'. Acting as an antioxidant by reducing oxidative stress, it is currently under consideration as a possible cancer treatment. | kaempferol |
| kaempferol 3-o-rhamnoside | A glycosyloxyflavone that is kaempferol attached to an alpha-L-rhamnosyl residue at position 3 via a glycosidic linkage. | afzelin |
| kalimantacin a | A fatty acid derivative isolated from the fermentation broth of Alcaligenes sp. YL-02632S. It is an antibiotic with antibacterial activity. | kalimantacin B |
| lactonamycin | An organic heterohexacyclic compound isolated from the culture broth of Streptomyces rishiriensis. It is an antibiotic with antibacterial activity. | lactonamycin |
| lauric acid | A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil. | dodecanoic acid |
| laurinterol | A sesquiterpenoid isolated from Laurencia intermedia and Aplysia kurodai and has been found to exhibit antibacterial activity, | laurinterol |
| licocoumarone | A member of the class of 1-benzofurans which consists of 1-benzofuran substituted by a hydroxy group at position 6, a methoxy group at position 4, a prenyl group at position 5 and a 2,4-dihydroxyphenyl group at position 2. It has been isolated from Glycyrrhiza uralensis. | licocoumarone |
| licoricidin | A member of the class of hydroxyisoflavans that is R-isoflavan with hydroxy groups at positions 7, 2' and 4', a methoxy group at position 5 and prenyl groups at positions 6 and 3'. Isolated from Glycyrrhiza uralensis, it exhibits antibacterial activity. | licoricidin |
| linolenyl alcohol | A long chain fatty primary alcohol that is octadecanol containing three double bonds located at positions 9, 12 and 15. | (9Z,12Z,15Z)-octadecatrien-1-ol |
| malachite green | An organic chloride salt that is the monochloride salt of malachite green cation. Used as a green-coloured dye, as a counter-stain in histology, and for its anti-fungal properties in aquaculture. | malachite green |
| mandelic acid | A 2-hydroxy monocarboxylic acid that is acetic acid in which two of the methyl hydrogens are substituted by phenyl and hydroxyl groups. | mandelic acid |
| manool | A labdane diterpenoid in which the labdane skeleton has double bonds at positions 8(17) and 14 and carries an R-hydroxy group at position 13. | manool |
| marinopyrrole a | A member of the class of pyrroles that is 1'H-1,3'-bipyrrole substituted by four chloro groups at positions 4, 4', 5 and 5' and two 2-hydroxybenzoyl moieties at positions 2 and 2'. It is isolated from Streptomyces sp.CNQ-418 and exhibits cytotoxic and antibacterial activities. | (-)-marinopyrrole A |
| mastoparan x | A member of the class of mastopyrans that is a 14-amino acid polypeptide comprising isoleucyl, asparaginyl, tryptophyl, lysyl, glycyl, isoleucyl, alanyl, alanyl, methionyl, alanyl, lysyl, lysyl, leucyl, and leucinamide residues coupled in sequence. It is the major active component of the venom of the hornet Vespa velutina and causes degranulation of mast cells. It exhibits antimicrobial activity against both Gram-positive and -negative bacteria as well as haemolytic activity on chicken, human and sheep erythrocytes. | mastoparan-V |
| meropenem | A carbapenemcarboxylic acid in which the azetidine and pyrroline rings carry 1-hydroxymethyl and in which the azetidine and pyrroline rings carry 1-hydroxymethyl and 5-(dimethylcarbamoyl)pyrrolidin-3-ylthio substituents respectively. | meropenem |
| methyl cinnamate | The E (trans) isomer of methyl cinnamate. | methyl trans-cinnamate |
| methylene bis(thiocyanate) | A member of the class of thiocyanates that is methane in which two of the hycrogens have been replaced by thiocyanato groups. Used as a biocide for the control of various pathogens and algae in industrial water systems and as a fungicide for the control of surface moulds and sapstain fungi on wood. | methylene bis(thiocyanate) |
| morin | A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5. | morin |
| my 12-62c | A quinolone consisting of quinolin-4(1H)-one carrying a heptyl substituent at position 2. | 2-heptyl-4-hydroxyquinoline; 2-heptyl-4-quinolone |
| my 12-62c | A monohydroxyquinoline that is 4-hydroxyquinoline bearing an additional heptyl substituent at position 2. | 2-heptyl-4-hydroxyquinoline; 2-heptyl-4-quinolone |
| naled | An dialkyl phosphate resulting from the formal condensation of the acidic hydroxy group of dimethyl hydrogen phosphate with the alcoholic hydroxy group of 1,2-dibromo-2,2-dichloroethanol. An organophosphate insecticide, it is no longer approved for use within the European Union. | naled |
| naphthazarin | A naphthoquinone that is 1,4-naphthoquinone in which the hydrogens at positions 5 and 8 are replaced by hydroxy groups. | naphthazarin |
| neamine | 2-Deoxy-D-streptamine glycosylated at the 4-oxygen with a 6-amino-alpha-D-glucosaminyl group. | neamine |
| nigericin | A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. | nigericin |
| nitrapyrin | A chloropyridine that is 2-chloropyridine which is substituted by a trichloromethyl group at position 6. It is a nitrification inhibitor that is co-applied with nitrogen fertilizer in agroecosystems. | nitrapyrin |
| novobiocin | A coumarin-derived antibiotic obtained from Streptomyces niveus. | novobiocin |
| nucleocidin | A nucleoside antibiotic that is 5'-O-sulfamoyladenosine in which the hydrogen atom at position 4' is replaced by a fluorine atom. It is a natural product synthesized by several Streptomyces species. It exhibits broad spectrum antibacterial activity, and also has a strong effect against Trypanosoma brucei, the protozoan parasite responsible for the African sleeping sickness. | nucleocidin |
| o-methyl threonine | An L-threonine derivative that is L-threonine with a methyl group replacing the hydrogen on the hydroxy side chain. | O-methyl-L-threonine |
| ochnaflavone | A biflavonoid with an ether linkage between the B-rings of the apigenin and luteolin subunits. It has been isolated from several members of the Ochnaceae plant family. | ochnaflavone |
| octanoic acid | A straight-chain saturated fatty acid that is heptane in which one of the hydrogens of a terminal methyl group has been replaced by a carboxy group. Octanoic acid is also known as caprylic acid. | octanoic acid |
| oridonin | An organic heteropentacyclic compound and ent-kaurane diterpenoid with formula C20H28O6 isolated from the leaves of the medicinal herb Rabdosia rubescens. | oridonin |
| oxacillin | A penicillin antibiotic carrying a 5-methyl-3-phenylisoxazole-4-carboxamide group at position 6beta. | oxacillin |
| oxetanocin a | A nucleoside analogue found in Bacillus megaterium in which an adenine moiety is attached to position 2 of a of an oxetane ring which is substituted at positions 3 and 4 by hydroxymethyl groups. | oxetanocin A |
| oxyquinoline | A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes. | quinolin-8-ol |
| phleomycin d1 | A glycopeptide originally isolated from the bacterium Streptomyces verticillus which contains a (4'R)-4',5'-dihydro-2,4'-bi-1,3-thiazole-2',4-diyl moiety with a a 4-guanidylbutylaminocarbonyl group attached to the 4-position of the terminal thiazole ring. Like all phleomycins, phleomycin D1 can form complexes with redox-active metals such as Co, Cu, and Fe. | phleomycin D1 |
| physcione | A dihydroxyanthraquinone that is 9,10-anthraquinone bearing hydroxy substituents at positions 1 and 8, a methoxy group at position 3, and a methyl group at position 6. It has been widely isolated and characterised from both terrestrial and marine sources. | physcion |
| platencin | A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the polycyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase. | platencin |
| platensimycin | A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the oxatetracyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase. | platensimycin |
| plaunotol | A diterpenoid that is geranylgeraniol carrying an additional hydroxy substituent at position 18. | plaunotol |
| proflavine | An aminoacridine that is acridine that is substituted by amino groups at positions 3 and 6. A slow-acting bacteriostat that is effective against many Gram-positive bacteria (but ineffective against spores), its salts were formerly used for treatment of burns and infected wounds. | 3,6-diaminoacridine |
| prunin protein, prunus | A flavanone 7-O-beta-D-glucoside that is (S)-naringenin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | naringenin 7-O-beta-D-glucoside |
| pyocyanine | An iminium betaine that is 5-methylphenazin-5-ium which is substituted at position 1 by an oxidanidyl group. An antibiotic pigment produced by Pseudomonas aeruginosa. | pyocyanine |
| pyoluteorin | A member of the class of resorcinols that is resorcinol in which the hydrogen at position 2 is replaced by a 4,5-dichloro-1H-pyrrole-2-carbonyl group. It is a natural product found in Pseudomonas fluorescens which exhibits antibacterial properties and is a strong inducer of caspase-3-dependent apoptosis. | pyoluteorin |
| pyrrolomycin a | A member of the class of pyrroles that is 1H-pyrrole which is substituted by chloro groups at positions 2 and 3 and by a nitro group position 4. It is the simplest member of the pyrrolomycins, a family of natural products found in several species of the Streptomyces genus. The compound is active against Gram-positive and Gram-negative bacteria and some genera of fungi. | pyrrolomycin A |
| quercetin | A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruit and wine. | quercetin |
| resorcinol monoacetate | A member of the class of phenols that is resorcinol in which one of the phenolic hydroxy groups has been converted into its acetate ester. It has keratolytic properties and has been used for the treatment of acne. | resorcinol monoacetate |
| rubiadin | A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 3 and a methyl group at position 2. It has been isolated from Rubia yunnanensis. | rubiadin |
| rubraxanthone | A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 3, 6 and 8, a geranyl group at position 1 and a methoxy group at position 2. Isolated from Mesua and Garcinia dioica, it exhibits antibacterial and cytotoxic activities. | rubraxanthone |
| senegalensin | A trihydroxyflavanone that is (S)-naringenin substituted by prenyl groups at positions 6 and 8. | 6,8-diprenylnaringenin |
| sigmoidin a | A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 3' and 4' and prenyl groups at positions 2' and 5'. Isolated from Erythrina sigmoidea, it exhibits anti-inflammatory and antioxidant activities. | sigmoidin A |
| sodium arsenite | An inoganic sodium salt with formula with formula NaAsO2. | sodium arsenite |
| sodium azide | The sodium salt of hydrogen azide (hydrazoic acid). | sodium azide |
| sofalcone | A member of the class of chalcones that is benzene in which the hydrogens at positions 1,2 and 5 are replaced by carboxymethoxy, (1E)-1-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-oxoprop-1-en-3-yl, and (3-methylbut-2-en-1-yl)oxy groups, respectively. It is a gastrointestinal drug currently used for treatment of gastritis and gastric ulcers in Japan and South Korea. | sofalcone |
| sophoraflavanone a | A trihydroxyflavanone that is (S)-naringenin substituted by a geranyl group at position 8. Isolated from Macaranga bicolor, it exhibits antibacterial and antineoplastic activities. | sophoraflavanone A |
| soranjidiol | A member of the class of hydroxyanthraquinones that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 6 and a methyl group at position 2. It has been isolated from the roots of Rubia yunnanensis. | 1,6-dihydroxy-2-methyl-9,10-anthraquinone |
| sulfaethoxypyridazine | A sulfonamide consisting of 6-ethoxypyridazine with a 4-aminobenzenesulfonamido group at the 3-position. Generally licensed for veterinary use only against bacterial infections, such as fowl cholera and salmonella infection. | sulfaethoxypyridazine |
| sulfamethoxazole | An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. | sulfamethoxazole |
| sulfanilamide | A sulfonamide in which the sulfamoyl functional group is attached to aniline at the 4-position. | sulfanilamide |
| surfactin A | A cyclodepsipeptide that is N-[(3R)-3-hydroxy-11-methyldodecanoyl]-L-alpha-glutamyl-L-leucyl-D-leucyl-L-valyl-L-alpha-aspartyl-D-leucyl-L-leucine in which the C-terminal carboxy group has been lactonised by condensation with the alcoholic hydroxy group. | surfactin A |
| surfactin c | A cyclodepsipeptide that is N-[(3R)-3-hydroxy-13-methyltetradecanoyl]-L-alpha-glutamyl-L-leucyl-D-leucyl-L-valyl-L-alpha-aspartyl-D-leucyl-L-leucine in which the C-terminal carboxy group has been lactonised by condensation with the alcoholic hydroxy group. | surfactin C |
| teixobactin | A cyclodepsipeptide that is isolated from the previously unculturable bacterial species Eleftheria terrae and is active against gram-positive bacteria. | teixobactin |
| terreic acid | | terreic acid |
| tert-butylhydroperoxide | An alkyl hydroperoxide in which the alkyl group is tert-butyl. It is widely used in a variety of oxidation processes. | tert-butyl hydroperoxide |
| thiazomycin | A heterodetic cyclic peptide isolated from Amycolatopsis fastidiosa. | thiazomycin |
| tirapazamine | A member of the class of benzotriazines that is 1,2,4-benzotriazine carrying an amino substituent at position 3 and two oxido substituents at positions 1 and 4. | tirapazamine |
| tobramycin | A amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring. | tobramycin |
| toxoflavin | A pyrimidotriazine that is 1,6-dimethyl-1,5,6,7-tetrahydropyrimido[5,4-e][1,2,4]triazine with oxo groups at positions 5 and 7. | toxoflavin |
| triclosan | An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. | triclosan |
| tropodithietic acid | A monocarboxylic acid that is 8,9-dithiabicyclo[5.2.0]nona-1,3,6-triene substituted by a carboxy group at position 2 and an oxo group at position 3. It is a broad spectrum antibiotic produced by the marine bacterium Phaeobacter inhibens that also acts as a signalling molecule at lower concentrations. | tropodithietic acid |
| tyrocidine | A homodetic cyclic decapeptide consisting of D-Phe, L-Pro, L-Phe, D-Phe, L-Asn, L-Gln, L-Tyr, L-Val, L-Orn, and L-Leu residues coupled in sequence and cyclised head-to-tail. | tyrocidine A |
| u-47929 | | ficellomycin |
| undecylprodigiosin | A member of the class of tripyrroles that is 1H-pyrrole substituted by (4'-methoxy-1H,5'H-[2,2'-bipyrrol]-5'-ylidene)methyl and undecyl groups at positions 2 and 5, respectively. It is a pigment produced by Stveptomyces coelicolor. | undecylprodigiosin |
| veronicastroside | A disaccharide derivative that is luteolin substituted by a 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | luteolin 7-O-neohesperidoside |
| vestitone | A hydroxyisoflavanone that is isoflavanone substituted by hydroxy groups at positions 7 and 2' and a methoxy group at position 4'. | vestitone |
| vinylamycin | A 15-membered cyclodepsipeptide isolated from Streptomyces sp.M1982-63F1. It exhibits moderate activity against Gram-positive bacteria. | vinylamycin |
| viridicatin | A hydroxyquinolone that is 3-hydroxyuinolin-2(1H)-one which is substituted at position 4 by a phenyl groups. Isolated from the mycelium of several Penicillium species, it exhibits strong antibiotic activity against M. tuberculosis and also against B. subtilis, S. aureus and S. cerevisiae. | viridicatin |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 19.1394 | 1 | 30 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 16.7811 | 1 | 21 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 11.3350 | 1 | 2 |
| 4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | Arabidopsis thaliana (thale cress) | Potency | 42.6224 | 1 | 2 |
| 67.9K protein | Vaccinia virus | Potency | 14.2748 | 2 | 22 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 48.3222 | 4 | 60 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 100.6636 | 1 | 2 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 34.2474 | 2 | 47 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Potency | 20.5348 | 1 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 24.2602 | 1 | 47 |
| alpha synuclein, partial | Homo sapiens (human) | Potency | 0.1515 | 1 | 1 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 33.4703 | 3 | 3 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 7.8790 | 1 | 18 |
| Amyloid-beta precursor protein | Homo sapiens (human) | Potency | 8.7592 | 1 | 2 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 15.2308 | 1 | 7 |
| AR protein | Homo sapiens (human) | Potency | 22.4858 | 12 | 295 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 31.2511 | 3 | 39 |
| arylsulfatase A | Homo sapiens (human) | Potency | 24.3219 | 1 | 5 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 18.5184 | 4 | 22 |
| Ataxin-2 | Homo sapiens (human) | Potency | 21.8980 | 2 | 30 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 10.6081 | 5 | 18 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 25.6179 | 2 | 42 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 11.8951 | 1 | 3 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 16.0576 | 1 | 3 |
| beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | Homo sapiens (human) | Potency | 0.1500 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 21.0374 | 4 | 20 |
| BRCA1 | Homo sapiens (human) | Potency | 10.8820 | 1 | 2 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 37.7592 | 1 | 10 |
| C-terminal-binding protein 1 | Homo sapiens (human) | Potency | 10.3704 | 1 | 2 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 29.9376 | 1 | 18 |
| Caspase-1 | Homo sapiens (human) | Potency | 2.3661 | 3 | 3 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 17.6414 | 2 | 6 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 34.6352 | 1 | 10 |
| caspase-3 | Homo sapiens (human) | Potency | 29.9376 | 1 | 18 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 34.6352 | 1 | 10 |
| Caspase-7 | Homo sapiens (human) | Potency | 12.2158 | 3 | 8 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 34.4188 | 3 | 95 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 9.7072 | 2 | 29 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 19.1028 | 1 | 39 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 14.5832 | 2 | 19 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 26.8717 | 2 | 8 |
| Chain A, Breast cancer type 1 susceptibility protein | Homo sapiens (human) | Potency | 1.2589 | 1 | 1 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 20.8882 | 3 | 29 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 31.0228 | 1 | 13 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 13.1041 | 2 | 38 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 51.7670 | 1 | 15 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 11.5413 | 3 | 37 |
| Chain A, PAPAIN | Carica papaya (papaya) | Potency | 28.1838 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 15.6706 | 3 | 25 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 12.5172 | 1 | 30 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 13.1041 | 2 | 38 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 56.8640 | 2 | 17 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 13.1006 | 1 | 11 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 12.3799 | 1 | 12 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 14.4154 | 1 | 12 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 10.5852 | 1 | 8 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 16.6478 | 1 | 11 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 17.3370 | 2 | 59 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 15.2442 | 2 | 22 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 24.1372 | 1 | 44 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 9.6002 | 3 | 7 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 0.6561 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 9.1000 | 1 | 9 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 19.7926 | 1 | 5 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | Potency | 20.8954 | 1 | 2 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 20.9500 | 1 | 6 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 22.7490 | 2 | 13 |
| DNA polymerase III, partial | Bacillus subtilis | Potency | 15.2332 | 1 | 4 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 42.9009 | 2 | 24 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 12.8410 | 2 | 31 |
| endonuclease IV | Escherichia coli | Potency | 12.2034 | 2 | 3 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Potency | 22.3872 | 1 | 1 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Potency | 22.3872 | 1 | 1 |
| enteropeptidase precursor | Homo sapiens (human) | Potency | 20.3866 | 1 | 2 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 26.9879 | 12 | 364 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 30.0965 | 3 | 69 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 20.1390 | 10 | 264 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 16.2702 | 1 | 33 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 11.0887 | 4 | 36 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 374.3823 | 3 | 4 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 32.8503 | 5 | 83 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | Potency | 44.6684 | 1 | 1 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 34.3101 | 2 | 24 |
| fructose-bisphosphate aldolase A | Oryctolagus cuniculus (rabbit) | Potency | 13.4270 | 1 | 2 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 23.1088 | 1 | 13 |
| G | Vesicular stomatitis virus | Potency | 14.4154 | 1 | 12 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| galactokinase | Homo sapiens (human) | Potency | 21.0741 | 2 | 5 |
| GALC protein | Homo sapiens (human) | Potency | 1.1080 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 17.3148 | 1 | 31 |
| geminin | Homo sapiens (human) | Potency | 13.5787 | 4 | 64 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 15.1442 | 3 | 98 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 9.1778 | 1 | 14 |
| GLS protein | Homo sapiens (human) | Potency | 15.0219 | 2 | 15 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 21.5714 | 6 | 25 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 26.5290 | 5 | 110 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 12.2382 | 2 | 3 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | Potency | 3.4703 | 1 | 2 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 24.7112 | 2 | 34 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | Potency | 3.4703 | 1 | 2 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | Potency | 3.4703 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | Potency | 0.1515 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | Potency | 0.1515 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | Potency | 0.1515 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | Potency | 0.1515 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | Potency | 0.1515 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | Homo sapiens (human) | Potency | 2.5119 | 1 | 1 |
| Glycoprotein hormones alpha chain | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 15.2976 | 1 | 4 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 23.9264 | 2 | 7 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 16.2399 | 2 | 12 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 26.9473 | 2 | 62 |
| hemoglobin subunit beta | Homo sapiens (human) | Potency | 12.2155 | 2 | 3 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 12.2382 | 2 | 3 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 13.7704 | 2 | 70 |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | Potency | 3.9811 | 1 | 3 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 16.2341 | 1 | 14 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 17.9587 | 2 | 22 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 48.0154 | 2 | 51 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 32.8360 | 1 | 6 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 14.4154 | 1 | 12 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 13.9251 | 1 | 16 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 21.9209 | 4 | 15 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 27.7664 | 2 | 54 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 19.8328 | 3 | 23 |
| IDH1 | Homo sapiens (human) | Potency | 13.5400 | 1 | 16 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 27.5822 | 2 | 7 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 14.4154 | 1 | 24 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 11.8613 | 2 | 15 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 9.2278 | 1 | 11 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 9.2278 | 1 | 11 |
| Interferon beta | Homo sapiens (human) | Potency | 18.5509 | 3 | 39 |
| interleukin 8 | Homo sapiens (human) | Potency | 61.4893 | 1 | 11 |
| isocitrate dehydrogenase 1, partial | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 7.0214 | 3 | 31 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 11.4779 | 1 | 20 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 15.8489 | 1 | 2 |
| Leukotriene B4 receptor 1 | Homo sapiens (human) | Potency | 0.1800 | 1 | 1 |
| Leukotriene B4 receptor 2 | Homo sapiens (human) | Potency | 0.1800 | 1 | 1 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 37.0828 | 4 | 37 |
| luciferase | Photuris pensylvanica (Pennsylania firefly) | Potency | 15.9010 | 3 | 6 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 3.1623 | 1 | 1 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 25.7835 | 1 | 8 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 13.9540 | 3 | 66 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 20.6738 | 2 | 14 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 14.6540 | 2 | 4 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 47.1029 | 3 | 6 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 5.1853 | 3 | 6 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 7.8871 | 2 | 10 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 7.4708 | 1 | 15 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 33.9252 | 1 | 4 |
| Nrf2 | Homo sapiens (human) | Potency | 18.7967 | 2 | 7 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 29.4684 | 4 | 117 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 12.1801 | 2 | 14 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 33.8904 | 1 | 11 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 31.4760 | 2 | 45 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 28.3621 | 1 | 16 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 37.4104 | 4 | 81 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 14.3986 | 1 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 28.9012 | 3 | 108 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| P53 | Homo sapiens (human) | Potency | 75.1137 | 1 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 62.7834 | 1 | 9 |
| Parkin | Homo sapiens (human) | Potency | 14.9536 | 3 | 10 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 27.8091 | 2 | 6 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 15.7596 | 2 | 18 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 44.6542 | 1 | 5 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 32.8775 | 5 | 102 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 30.4097 | 5 | 96 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 14.7784 | 3 | 5 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 42.2545 | 1 | 30 |
| PINK1 | Homo sapiens (human) | Potency | 13.7555 | 1 | 5 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 8.6120 | 1 | 14 |
| polyprotein | Zika virus | Potency | 23.1088 | 1 | 13 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 11.1964 | 1 | 13 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 15.2426 | 1 | 17 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 22.3147 | 1 | 18 |
| PPM1D protein | Homo sapiens (human) | Potency | 17.8910 | 1 | 14 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 31.4003 | 3 | 52 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 41.5511 | 1 | 11 |
| progesterone receptor | Homo sapiens (human) | Potency | 29.3920 | 2 | 46 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 16.8088 | 5 | 7 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 5.1189 | 4 | 4 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 10.0000 | 2 | 2 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 49.2768 | 2 | 9 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 67.6509 | 2 | 8 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 17.6782 | 2 | 86 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 32.8898 | 1 | 5 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 18.8841 | 1 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 24.7894 | 3 | 120 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 18.6850 | 4 | 108 |
| RGS12 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 20.3510 | 1 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 9.4924 | 3 | 6 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 12.6983 | 1 | 8 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Potency | 5.7988 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | Homo sapiens (human) | Potency | 16.1717 | 3 | 5 |
| Single-stranded DNA cytosine deaminase | Homo sapiens (human) | Potency | 50.1187 | 1 | 3 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 31.5214 | 2 | 41 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 31.5214 | 2 | 41 |
| Smad3 | Homo sapiens (human) | Potency | 14.8032 | 1 | 18 |
| snurportin-1 | Homo sapiens (human) | Potency | 27.5822 | 2 | 7 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 13.9581 | 2 | 13 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 18.2344 | 1 | 25 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 16.8711 | 1 | 14 |
| TDP1 protein | Homo sapiens (human) | Potency | 12.5711 | 2 | 133 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 52.5714 | 1 | 5 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 34.2304 | 3 | 22 |
| Thrombopoietin | Homo sapiens (human) | Potency | 2.7733 | 2 | 6 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 18.3110 | 3 | 107 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 36.0462 | 4 | 35 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 25.5686 | 7 | 121 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 22.2800 | 2 | 20 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 48.2794 | 2 | 4 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 21.4215 | 1 | 2 |
| TSHR protein | Homo sapiens (human) | Potency | 2.1331 | 1 | 1 |
| tumor necrosis factor | Homo sapiens (human) | Potency | 58.5706 | 1 | 2 |
| tumor susceptibility gene 101 protein | Homo sapiens (human) | Potency | 10.0000 | 1 | 2 |
| tyrosine-protein kinase Yes | Homo sapiens (human) | Potency | 8.9264 | 1 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 14.3736 | 6 | 17 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 8.6120 | 1 | 14 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 8.6120 | 1 | 14 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 42.4332 | 2 | 23 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 19.2315 | 2 | 57 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 23.6229 | 5 | 65 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 30.3408 | 1 | 23 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 26.0387 | 1 | 32 |
| Vpr | Human immunodeficiency virus 1 | Potency | 38.8312 | 1 | 5 |
| WRN | Homo sapiens (human) | Potency | 13.7848 | 2 | 5 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 3.2851 | 7 | 10 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli K-12 | IC50 | 2.0500 | 1 | 2 |
| 10 kDa chaperonin | Escherichia coli | IC50 | 11.9750 | 2 | 8 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 10.2750 | 1 | 4 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | IC50 | 1.0500 | 1 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | IC50 | 0.9500 | 2 | 4 |
| 26S proteasome non-ATPase regulatory subunit 14 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 2 | Staphylococcus aureus | IC50 | 4.5800 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli | IC50 | 850.0000 | 1 | 1 |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 3.9000 | 1 | 3 |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| 30S ribosomal protein S1 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S10 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S11 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S12 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S13 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S14 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S15 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S16 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S17 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S18 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S19 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S2 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S20 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S21 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S3 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S4 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S5 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S6 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S7 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S8 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 30S ribosomal protein S9 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | IC50 | 12,800.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 4.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.1710 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 1.3780 | 1 | 2 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 4.7000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.6800 | 3 | 4 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 2 | 2 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 5.6947 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 1.8714 | 2 | 2 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 2 | 2 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 2.8156 | 1 | 2 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 1.0926 | 2 | 3 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 2 | 2 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 2.8156 | 1 | 2 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 1.4748 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 275.0000 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 0.0430 | 1 | 1 |
| 5-lipoxygenase | Bos taurus (cattle) | IC50 | 3.0000 | 1 | 1 |
| 5'-nucleotidase | Rattus norvegicus (Norway rat) | Ki | 0.0453 | 1 | 1 |
| 50S ribosomal protein L1 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L10 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L11 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L13 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L14 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L15 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L16 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L17 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L18 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L19 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L2 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L20 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L21 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L22 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L23 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L24 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L25 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L27 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L28 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L29 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L3 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L30 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L31 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L32 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L33 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L34 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L35 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L36 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L4 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L5 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L6 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | IC50 | 5.0000 | 2 | 2 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 225.7500 | 1 | 4 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 11.9750 | 2 | 8 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 10.2750 | 1 | 4 |
| 72 kDa type IV collagenase | Homo sapiens (human) | IC50 | 9.0219 | 16 | 16 |
| 72 kDa type IV collagenase | Homo sapiens (human) | Ki | 0.0004 | 3 | 3 |
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | IC50 | 33.6855 | 2 | 6 |
| A disintegrin and metalloproteinase with thrombospondin motifs 4 | Homo sapiens (human) | IC50 | 0.4800 | 1 | 1 |
| A disintegrin and metalloproteinase with thrombospondin motifs 5 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| Acetylcholinesterase | Anopheles gambiae (African malaria mosquito) | IC50 | 0.1920 | 2 | 2 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 28.0050 | 2 | 2 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 19.1335 | 8 | 10 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 65.5500 | 1 | 2 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | IC50 | 0.0700 | 1 | 1 |
| Adenomatous polyposis coli protein | Homo sapiens (human) | Ki | 118.0000 | 2 | 2 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 8.9000 | 3 | 3 |
| Adenosine receptor A2a | Homo sapiens (human) | IC50 | 2.4894 | 1 | 2 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 1.3975 | 1 | 2 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 5.1250 | 2 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 1.9126 | 1 | 3 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 13.4486 | 3 | 5 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | Homo sapiens (human) | IC50 | 37.9000 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | IC50 | 2.3200 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | IC50 | 38.4000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | IC50 | 17.7540 | 5 | 5 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 3.0461 | 8 | 9 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 5.0971 | 6 | 9 |
| Aldo-keto reductase family 1 member B1 | Sus scrofa (pig) | IC50 | 50.1000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 2.3280 | 1 | 2 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | IC50 | 0.1833 | 3 | 3 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | Ki | 0.0460 | 1 | 1 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 21.1200 | 2 | 2 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 15.8800 | 2 | 2 |
| Aldo-keto reductase family 1 member C21 | Mus musculus (house mouse) | IC50 | 6.9000 | 1 | 1 |
| Aldo-keto reductase family 1 member C21 | Mus musculus (house mouse) | Ki | 11.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 2.7050 | 2 | 2 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 5.2750 | 2 | 2 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | IC50 | 0.3752 | 12 | 12 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | Ki | 0.0062 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 1.9126 | 1 | 3 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0810 | 1 | 3 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 17.1076 | 2 | 5 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0810 | 1 | 3 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 1.9800 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.9730 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 3.0448 | 1 | 3 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 1.0215 | 2 | 4 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 0.9505 | 1 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 0.4340 | 1 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 3.6068 | 1 | 3 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 0.3187 | 2 | 5 |
| Alpha-amylase 1A | Homo sapiens (human) | IC50 | 21.4000 | 2 | 2 |
| Alpha-synuclein | Homo sapiens (human) | IC50 | 14.1000 | 1 | 2 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 1.9680 | 4 | 5 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 0.2200 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Bos taurus (cattle) | IC50 | 0.0100 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | IC50 | 20.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 49.5533 | 3 | 3 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 44.3954 | 8 | 13 |
| Androgen receptor | Homo sapiens (human) | IC50 | 9.7000 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 8.0116 | 2 | 3 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 3.5150 | 1 | 2 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 0.1085 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 0.0889 | 1 | 1 |
| Angiotensin-converting enzyme | Homo sapiens (human) | Ki | 167.0000 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 0.6700 | 1 | 1 |
| Anthrax toxin receptor 2 | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | IC50 | 61.7500 | 2 | 2 |
| Arginase | Leishmania amazonensis | IC50 | 29.5000 | 1 | 2 |
| Arginase | Leishmania amazonensis | Ki | 0.7000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | IC50 | 6.0060 | 2 | 2 |
| Aromatic-L-amino-acid decarboxylase | Homo sapiens (human) | IC50 | 1,280.0000 | 1 | 1 |
| Arrestin, beta 1 | Homo sapiens (human) | IC50 | 1.5240 | 1 | 1 |
| Aryl hydrocarbon receptor | Homo sapiens (human) | IC50 | 0.0280 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 6 |
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | IC50 | 57.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 46.7500 | 2 | 2 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 0.1525 | 2 | 2 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 3.9012 | 4 | 8 |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | IC50 | 4.0000 | 2 | 2 |
| Bcl-2-like protein 1 | Homo sapiens (human) | IC50 | 46.3571 | 5 | 7 |
| Bcl-2-like protein 11 | Homo sapiens (human) | IC50 | 13.4375 | 4 | 8 |
| bcl-2-related protein A1 | Mus musculus (house mouse) | IC50 | 20.0000 | 1 | 1 |
| BDNF/NT-3 growth factors receptor | Homo sapiens (human) | IC50 | 0.0037 | 7 | 7 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 12.1857 | 5 | 7 |
| Beta-glucuronidase | Homo sapiens (human) | IC50 | 36.4700 | 1 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 4.7500 | 1 | 2 |
| Beta-lactamase | Enterobacter cloacae | IC50 | 269.6667 | 3 | 3 |
| Beta-lactamase | Escherichia coli K-12 | IC50 | 58.0000 | 4 | 4 |
| Beta-lactamase | Escherichia coli | IC50 | 0.0260 | 1 | 1 |
| Beta-lactamase | Klebsiella pneumoniae | IC50 | 0.0040 | 1 | 1 |
| Beta-lactamase TEM | Escherichia coli | Ki | 13.0000 | 1 | 1 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 8.8050 | 4 | 4 |
| Beta-secretase 1 | Homo sapiens (human) | Ki | 14.0000 | 1 | 1 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 7.2617 | 6 | 6 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 355.9513 | 4 | 15 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 376.7000 | 1 | 1 |
| Botulinum neurotoxin type A | Clostridium botulinum | IC50 | 16.4250 | 2 | 4 |
| BRCA1-associated RING domain protein 1 | Homo sapiens (human) | IC50 | 3.8900 | 1 | 1 |
| Breast cancer type 1 susceptibility protein | Homo sapiens (human) | IC50 | 3.8900 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 34.5558 | 8 | 12 |
| BZLF2 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 5.9700 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | IC50 | 4.1770 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | Ki | 1.6140 | 1 | 1 |
| C-C chemokine receptor type 4 | Homo sapiens (human) | IC50 | 47.2409 | 3 | 6 |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | IC50 | 35.3780 | 2 | 4 |
| Cadherin-1 | Homo sapiens (human) | Ki | 16.5000 | 2 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Rattus norvegicus (Norway rat) | IC50 | 275.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Rattus norvegicus (Norway rat) | IC50 | 275.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Calmodulin-1 | Homo sapiens (human) | IC50 | 12.9700 | 1 | 1 |
| calpain II, partial | Sus scrofa (pig) | IC50 | 3.7336 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 6.7533 | 3 | 3 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 5 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | Ki | 7.9500 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | IC50 | 3.3100 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 1.4190 | 3 | 3 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 0.4400 | 1 | 1 |
| Cannabinoid receptor 2 | Mus musculus (house mouse) | IC50 | 100.0000 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | IC50 | 3.4600 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 1.2382 | 4 | 4 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 6.2552 | 4 | 5 |
| Carbonic anhydrase | Helicobacter pylori 26695 | Ki | 0.4425 | 2 | 2 |
| Carbonic anhydrase | Methanosarcina thermophila | Ki | 3,480.8360 | 5 | 5 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 57.8000 | 1 | 1 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 18.5000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.3000 | 1 | 1 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 0.8620 | 1 | 1 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 13,903.8500 | 2 | 2 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 0.7675 | 2 | 2 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 6.6750 | 2 | 2 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ki | 8.0110 | 1 | 1 |
| Carbonic anhydrase | Pseudomonas aeruginosa PAO1 | Ki | 770.0000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.3640 | 2 | 2 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.6520 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 14.9040 | 1 | 3 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 515,472,496.4943 | 88 | 109 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 3.8617 | 18 | 18 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 3.2657 | 3 | 3 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 3.0313 | 3 | 3 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 4.6450 | 6 | 6 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 6.4202 | 4 | 5 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 7.8754 | 5 | 7 |
| Carbonic anhydrase 2 | Bos taurus (cattle) | Ki | 12.9850 | 1 | 2 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 309.2908 | 110 | 134 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 19.0375 | 2 | 4 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 9.6478 | 2 | 9 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 274.2720 | 4 | 4 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | Ki | 315,773,689.0134 | 13 | 19 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 4,077.3125 | 9 | 16 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | IC50 | 32.0000 | 1 | 1 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 54.8375 | 6 | 8 |
| Carbonic anhydrase 5A, mitochondrial | Mus musculus (house mouse) | Ki | 8.1650 | 1 | 4 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 9.1817 | 4 | 6 |
| Carbonic anhydrase 6 | Homo sapiens (human) | IC50 | 14.9040 | 1 | 3 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 5.8223 | 9 | 12 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 1.4493 | 7 | 7 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 4.1960 | 3 | 3 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 11.9554 | 30 | 34 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.6280 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | Ki | 0.0600 | 1 | 1 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | IC50 | 9.9330 | 1 | 1 |
| Carboxypeptidase A1 | Bos taurus (cattle) | IC50 | 2.7600 | 1 | 1 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 4.5136 | 6 | 11 |
| Casein kinase II subunit alpha | Homo sapiens (human) | Ki | 1.1800 | 4 | 4 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | IC50 | 5.2375 | 1 | 4 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | Ki | 1.1800 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 4.5136 | 6 | 11 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Ki | 1.1800 | 1 | 1 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 4.5136 | 6 | 11 |
| Casein kinase II subunit beta | Homo sapiens (human) | Ki | 1.1800 | 1 | 1 |
| Caspase-1 | Homo sapiens (human) | IC50 | 4.0400 | 1 | 1 |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | IC50 | 46.7000 | 1 | 1 |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | IC50 | 46.7000 | 1 | 1 |
| Catechol O-methyltransferase | Homo sapiens (human) | IC50 | 2.3736 | 2 | 2 |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | IC50 | 10.5964 | 1 | 3 |
| Catenin beta-1 | Homo sapiens (human) | IC50 | 82.9600 | 5 | 5 |
| Catenin beta-1 | Homo sapiens (human) | Ki | 4.7750 | 4 | 4 |
| Cathepsin B | Homo sapiens (human) | IC50 | 0.0467 | 2 | 2 |
| Cathepsin B | Homo sapiens (human) | Ki | 8.6000 | 1 | 1 |
| cathepsin S isoform 1 preproprotein | Homo sapiens (human) | IC50 | 0.1765 | 1 | 1 |
| Cationic trypsin | Bos taurus (cattle) | IC50 | 48.4000 | 2 | 7 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | IC50 | 19.0700 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | Ki | 0.8145 | 1 | 2 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 81.3000 | 1 | 1 |
| Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | Helicobacter pylori | Ki | 12.7000 | 1 | 3 |
| Chain A, APH(2')-Id | Enterococcus casseliflavus | Ki | 25.1000 | 1 | 1 |
| Chain A, Bacterial leucyl aminopeptidase | Vibrio proteolyticus | Ki | 0.5800 | 1 | 1 |
| Chain A, Diaminopimelate decarboxylase | Methanocaldococcus jannaschii | Ki | 89.0000 | 1 | 1 |
| Chain A, enoyl-acyl carrier reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0500 | 1 | 3 |
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | IC50 | 35.0600 | 1 | 1 |
| Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | Helicobacter pylori | Ki | 12.7000 | 1 | 3 |
| Chain B, Diaminopimelate decarboxylase | Methanocaldococcus jannaschii | Ki | 89.0000 | 1 | 1 |
| Chain C, enoyl-acyl carrier reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0500 | 1 | 3 |
| Cholinesterase | Equus caballus (horse) | IC50 | 10.4740 | 2 | 2 |
| Cholinesterase | Homo sapiens (human) | IC50 | 49.1567 | 3 | 3 |
| Chymotrypsin-C | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Chymotrypsin-like elastase family member 1 | Sus scrofa (pig) | IC50 | 28.7500 | 1 | 4 |
| Chymotrypsinogen A | Bos taurus (cattle) | IC50 | 292.5000 | 2 | 2 |
| Chymotrypsinogen B | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Class A sortase SrtA | Staphylococcus aureus | IC50 | 31.2600 | 3 | 3 |
| Collagenase 3 | Homo sapiens (human) | IC50 | 2.1177 | 4 | 4 |
| Collagenase ColG | Hathewaya histolytica | IC50 | 24.0000 | 1 | 1 |
| Cyclin homolog | Herpesvirus saimiri (strain 11) | IC50 | 30.3250 | 1 | 8 |
| Cyclin-A2 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 25.3343 | 4 | 7 |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | IC50 | 30.3250 | 1 | 8 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 | 20.5000 | 2 | 2 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | IC50 | 61.0000 | 1 | 1 |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | IC50 | 31.6600 | 2 | 10 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | IC50 | 28.9600 | 2 | 10 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | IC50 | 31.6600 | 2 | 10 |
| Cysteine protease | Trypanosoma brucei rhodesiense | Ki | 5.3100 | 1 | 1 |
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | IC50 | 8.8800 | 1 | 1 |
| Cytochrome P450 11B1, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 2 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 6.6620 | 6 | 7 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 1.5725 | 2 | 4 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 16.1838 | 6 | 7 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 2.2200 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 2.2287 | 6 | 7 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 0.0872 | 2 | 4 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 5.6132 | 2 | 2 |
| Cytochrome P450 2C8 | Homo sapiens (human) | IC50 | 13.5000 | 2 | 2 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 19.5000 | 2 | 2 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 16.5000 | 1 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 29.6874 | 6 | 6 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 24.6417 | 8 | 8 |
| Cytosol aminopeptidase | Sus scrofa (pig) | IC50 | 34.3000 | 1 | 1 |
| Cytosolic phospholipase A2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| D | Rattus norvegicus (Norway rat) | Ki | 2.9000 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | IC50 | 3.7570 | 1 | 2 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 1.8785 | 1 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | IC50 | 3.1780 | 1 | 1 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 1.0590 | 1 | 1 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 2.8000 | 1 | 1 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 2.1455 | 1 | 2 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.7285 | 1 | 2 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 7.8460 | 1 | 1 |
| Death-associated protein kinase 1 | Homo sapiens (human) | IC50 | 30.3000 | 2 | 5 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 0.1810 | 1 | 1 |
| delta-type opioid receptor | Homo sapiens (human) | IC50 | 32.0000 | 1 | 2 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 14.4000 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 12.6200 | 2 | 2 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.2400 | 1 | 1 |
| Deoxyhypusine hydroxylase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Deoxyribonuclease-1 | Homo sapiens (human) | IC50 | 0.3500 | 1 | 1 |
| Diacylglycerol lipase-alpha | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Dihydrofolate reductase | Pneumocystis carinii | IC50 | 0.1000 | 1 | 1 |
| Dihydroorotate dehydrogenase | Leishmania major | IC50 | 248.1018 | 1 | 4 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | IC50 | 0.1300 | 1 | 1 |
| Dihydropteroate synthase | Escherichia coli K-12 | IC50 | 4.7000 | 1 | 1 |
| Dipeptidyl peptidase 3 | Homo sapiens (human) | IC50 | 64.0000 | 1 | 3 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 115.0683 | 2 | 6 |
| Disintegrin and metalloproteinase domain-containing protein 10 | Homo sapiens (human) | IC50 | 0.1356 | 2 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 12 | Homo sapiens (human) | IC50 | 0.0059 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | IC50 | 0.1125 | 3 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 9 | Homo sapiens (human) | IC50 | 0.0286 | 2 | 2 |
| DNA gyrase subunit A | Escherichia coli K-12 | IC50 | 91.0401 | 11 | 11 |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | IC50 | 3.9538 | 12 | 12 |
| DNA gyrase subunit A | Staphylococcus aureus | IC50 | 0.0383 | 13 | 13 |
| DNA gyrase subunit A | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
| DNA gyrase subunit A | Staphylococcus aureus | Ki | 0.0360 | 2 | 4 |
| DNA gyrase subunit B | Escherichia coli K-12 | IC50 | 62.6441 | 16 | 16 |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | IC50 | 4.2224 | 11 | 11 |
| DNA gyrase subunit B | Mycolicibacterium smegmatis | IC50 | 25.8523 | 7 | 7 |
| DNA gyrase subunit B | Mycolicibacterium smegmatis MC2 155 | IC50 | 0.0460 | 1 | 1 |
| DNA gyrase subunit B | Staphylococcus aureus | IC50 | 0.0474 | 19 | 19 |
| DNA gyrase subunit B | Streptococcus pneumoniae TIGR4 | IC50 | 0.0370 | 1 | 1 |
| DNA gyrase subunit B | Escherichia coli K-12 | Ki | 0.0353 | 2 | 4 |
| DNA gyrase subunit B | Staphylococcus aureus | Ki | 0.0360 | 2 | 4 |
| DNA topoisomerase | Streptococcus pneumoniae | IC50 | 2.0300 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | IC50 | 256.0000 | 1 | 1 |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | IC50 | 25.6000 | 5 | 5 |
| DNA topoisomerase 4 subunit A | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | IC50 | 22.6500 | 6 | 6 |
| DNA topoisomerase 4 subunit B | Escherichia coli K-12 | Ki | 0.0447 | 1 | 3 |
| DNA-3-methyladenine glycosylase | Homo sapiens (human) | IC50 | 2.6000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | IC50 | 2.5222 | 4 | 4 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | IC50 | 0.8000 | 2 | 2 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Dual specificity protein phosphatase 1 | Mus musculus (house mouse) | IC50 | 9.3700 | 1 | 1 |
| dual specificity protein phosphatase 3 | Homo sapiens (human) | IC50 | 1.1700 | 2 | 2 |
| dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | IC50 | 61.8440 | 5 | 5 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | IC50 | 12.5600 | 1 | 1 |
| E3 ubiquitin-protein ligase Mdm2 isoform a | Homo sapiens (human) | IC50 | 3.5800 | 1 | 1 |
| E3 ubiquitin-protein ligase XIAP | Homo sapiens (human) | IC50 | 100.0000 | 1 | 2 |
| Echinoderm microtubule-associated protein-like 4 | Homo sapiens (human) | IC50 | 0.3307 | 3 | 3 |
| Efflux transporter | Salmonella enterica subsp. enterica serovar Newport | IC50 | 0.0040 | 1 | 1 |
| ELAV-like protein 1 | Homo sapiens (human) | IC50 | 1.4000 | 1 | 1 |
| ELAV-like protein 3 | Homo sapiens (human) | IC50 | 1.8000 | 1 | 1 |
| Endoplasmic reticulum chaperone BiP | Homo sapiens (human) | IC50 | 31.8250 | 3 | 4 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | IC50 | 223.3333 | 3 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | IC50 | 2.8712 | 8 | 8 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | Ki | 0.2100 | 4 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Francisella tularensis subsp. tularensis SCHU S4 | IC50 | 4.3300 | 5 | 5 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 0.5000 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Escherichia coli K-12 | IC50 | 4.2688 | 9 | 13 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Haemophilus influenzae Rd KW20 | IC50 | 7.6425 | 2 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Staphylococcus aureus subsp. aureus MRSA252 | IC50 | 2.6049 | 10 | 14 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Staphylococcus aureus subsp. aureus MRSA252 | Ki | 0.0000 | 1 | 1 |
| Enoyl-ACP reductase II | Streptococcus pneumoniae | IC50 | 32.0000 | 2 | 2 |
| Enoyl-acyl carrier reductase | Toxoplasma gondii | IC50 | 0.0167 | 3 | 3 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 2.3998 | 11 | 13 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.1264 | 20 | 20 |
| envelope glycoprotein | Human immunodeficiency virus 1 | IC50 | 4.8000 | 3 | 3 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 25.0325 | 5 | 9 |
| Epoxide hydrolase 1 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 7.9120 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | Ki | 2.2600 | 1 | 1 |
| Estrogen receptor 1 | Homo sapiens (human) | IC50 | 2.1616 | 1 | 1 |
| estrogen receptor beta isoform 1 | Homo sapiens (human) | IC50 | 1.9842 | 1 | 3 |
| Eukaryotic elongation factor 2 kinase | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Eukaryotic translation initiation factor 2-alpha kinase 3 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | IC50 | 9.5437 | 1 | 2 |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | IC50 | 9.5437 | 1 | 2 |
| exodeoxyribonuclease V subunit RecB | Escherichia coli str. K-12 substr. MG1655 | IC50 | 88.7400 | 2 | 3 |
| exodeoxyribonuclease V subunit RecC | Escherichia coli str. K-12 substr. MG1655 | IC50 | 88.7400 | 2 | 3 |
| exodeoxyribonuclease V subunit RecD | Escherichia coli str. K-12 substr. MG1655 | IC50 | 88.7400 | 2 | 3 |
| fatty acid synthase | Homo sapiens (human) | IC50 | 6.7350 | 2 | 2 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Focal adhesion kinase 1 | Homo sapiens (human) | IC50 | 0.6700 | 2 | 2 |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | IC50 | 29.0000 | 1 | 1 |
| Furin | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | IC50 | 8.7000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | IC50 | 15.0667 | 1 | 3 |
| G-protein coupled receptor 84 | Homo sapiens (human) | Ki | 7.8500 | 1 | 3 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | IC50 | 61.0000 | 1 | 1 |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | IC50 | 30.3250 | 1 | 8 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 | 29.4817 | 3 | 6 |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | IC50 | 58.0000 | 1 | 2 |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | IC50 | 58.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 41.6241 | 1 | 2 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | IC50 | 0.7420 | 5 | 5 |
| Genome polyprotein | Human rhinovirus sp. | IC50 | 150.0000 | 1 | 1 |
| Genome polyprotein | Zika virus | IC50 | 14.2000 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 19.0000 | 1 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 36.2500 | 1 | 2 |
| glucose-6-phosphate dehydrogenase | Leuconostoc mesenteroides | IC50 | 25.0000 | 1 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 26.9017 | 3 | 6 |
| Glutaminyl-peptide cyclotransferase | Homo sapiens (human) | IC50 | 208.0000 | 1 | 1 |
| Glutathione reductase | Saccharomyces cerevisiae S288C | IC50 | 48.8000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | IC50 | 218.0000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Ki | 192.0000 | 1 | 1 |
| Glutathione S-transferase Mu 1 | Mus musculus (house mouse) | IC50 | 100.0000 | 1 | 1 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | Trypanosoma cruzi | IC50 | 142.0000 | 1 | 1 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | IC50 | 102.7645 | 1 | 2 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | IC50 | 2.8000 | 1 | 2 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 5.2000 | 2 | 3 |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | IC50 | 30.3250 | 1 | 8 |
| green fluorescent protein, partial | Aequorea victoria | IC50 | 67.5490 | 1 | 2 |
| Group 10 secretory phospholipase A2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| heat shock 70kDa protein 1A | Homo sapiens (human) | IC50 | 46.2333 | 3 | 3 |
| heat shock cognate 71 kDa protein isoform 1 | Homo sapiens (human) | IC50 | 63.7000 | 2 | 2 |
| heat shock cognate 71 kDa protein isoform 2 | Homo sapiens (human) | IC50 | 63.7000 | 2 | 2 |
| Heat shock factor protein 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Heat shock protein HSP 90 | Oryctolagus cuniculus (rabbit) | IC50 | 382.0000 | 2 | 2 |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | IC50 | 33.6855 | 2 | 6 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | IC50 | 231.0000 | 1 | 1 |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 2 |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 2 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | IC50 | 5.2900 | 2 | 2 |
| hepatocyte nuclear factor 4-alpha isoform 2 | Homo sapiens (human) | IC50 | 26.3363 | 2 | 3 |
| hexokinase | Trypanosoma brucei brucei TREU927 | IC50 | 11.6394 | 2 | 2 |
| hexokinase HKDC1 | Homo sapiens (human) | IC50 | 44.4950 | 2 | 2 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | IC50 | 0.0059 | 12 | 12 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 6.6716 | 2 | 6 |
| Histamine H2 receptor | Homo sapiens (human) | IC50 | 1.1550 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 5.8808 | 3 | 7 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 3.3388 | 5 | 9 |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | Ki | 2.7460 | 5 | 11 |
| Histamine H4 receptor | Homo sapiens (human) | Ki | 6.6716 | 2 | 6 |
| Histone acetyltransferase KAT2B | Homo sapiens (human) | IC50 | 19.4500 | 4 | 4 |
| Histone acetyltransferase KAT5 | Homo sapiens (human) | IC50 | 64.0000 | 1 | 1 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | IC50 | 43.0000 | 1 | 1 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | Ki | 64.0000 | 1 | 1 |
| Histone acetyltransferase p300 | Homo sapiens (human) | IC50 | 7.4125 | 4 | 4 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 1 | Homo sapiens (human) | Ki | 2.5000 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 2 | Homo sapiens (human) | Ki | 0.0154 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 4 | Homo sapiens (human) | Ki | 20.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 66.5733 | 2 | 15 |
| Histone deacetylase 5 | Homo sapiens (human) | Ki | 2.5000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 59.6941 | 4 | 17 |
| Histone deacetylase 6 | Homo sapiens (human) | Ki | 2.5000 | 1 | 1 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Histone deacetylase 8 | Homo sapiens (human) | Ki | 0.1780 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 66.5933 | 2 | 15 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 0.7300 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 103.0100 | 1 | 2 |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | IC50 | 2.7500 | 2 | 2 |
| Hypoxia-inducible factor 1-alpha inhibitor | Homo sapiens (human) | IC50 | 10.2000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 750.0000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | Ki | 0.0940 | 3 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 15.0200 | 3 | 5 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Ki | 2.7600 | 2 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 homolog | Mus musculus (house mouse) | IC50 | 10.1000 | 3 | 3 |
| Inhibin alpha chain | Homo sapiens (human) | IC50 | 5.2000 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | IC50 | 1.6000 | 1 | 2 |
| Inositol polyphosphate multikinase | Homo sapiens (human) | IC50 | 3.3500 | 1 | 2 |
| Insulin receptor | Homo sapiens (human) | IC50 | 0.2090 | 1 | 1 |
| Insulin-degrading enzyme | Homo sapiens (human) | IC50 | 33.3520 | 3 | 3 |
| Insulin-degrading enzyme | Mus musculus (house mouse) | IC50 | 200.0000 | 1 | 1 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | IC50 | 0.2110 | 2 | 2 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 1,940.3358 | 15 | 24 |
| integrase, partial | Human immunodeficiency virus 1 | IC50 | 14.1368 | 2 | 4 |
| Interstitial collagenase | Homo sapiens (human) | IC50 | 0.7758 | 12 | 15 |
| Interstitial collagenase | Homo sapiens (human) | Ki | 0.0004 | 1 | 1 |
| Islet amyloid polypeptide | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens (human) | Ki | 50.0000 | 1 | 1 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 1.0000 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | IC50 | 1.5400 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 0.6160 | 1 | 1 |
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | IC50 | 18.5875 | 2 | 4 |
| KiSS-1 receptor | Homo sapiens (human) | Ki | 3.6000 | 1 | 1 |
| Laccase | Trametes versicolor | IC50 | 266.3333 | 3 | 3 |
| Lactoperoxidase | Bos taurus (cattle) | IC50 | 6.1000 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | IC50 | 11.6000 | 1 | 3 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 22.6675 | 1 | 2 |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| large T antigen | Betapolyomavirus macacae | IC50 | 24.2050 | 2 | 2 |
| Lecithin retinol acyltransferase | Homo sapiens (human) | IC50 | 133.9000 | 1 | 4 |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | IC50 | 14.1368 | 2 | 4 |
| Lethal factor | Bacillus anthracis | Ki | 42.9000 | 3 | 3 |
| Linoleate 9S-lipoxygenase-4 | Glycine max (soybean) | IC50 | 22.0000 | 1 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | Bos taurus (cattle) | IC50 | 10.0000 | 1 | 1 |
| Lysine-specific demethylase 4A | Homo sapiens (human) | IC50 | 2.5000 | 2 | 2 |
| Lysine-specific demethylase 4B | Homo sapiens (human) | IC50 | 3.8000 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | IC50 | 0.5205 | 2 | 2 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | Ki | 4.3300 | 1 | 1 |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | IC50 | 4.6660 | 4 | 5 |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | IC50 | 253.9000 | 2 | 2 |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | IC50 | 57.9900 | 1 | 1 |
| Macrophage metalloelastase | Homo sapiens (human) | IC50 | 1.2838 | 8 | 8 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 4.2000 | 1 | 2 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | Ki | 3.0600 | 2 | 4 |
| Malate dehydrogenase | Thermus thermophilus | IC50 | 6.0000 | 1 | 1 |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | IC50 | 9.3000 | 2 | 2 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Matrilysin | Homo sapiens (human) | IC50 | 0.0190 | 2 | 2 |
| Matrix metalloproteinase-14 | Homo sapiens (human) | IC50 | 0.0102 | 10 | 10 |
| Matrix metalloproteinase-15 | Homo sapiens (human) | IC50 | 0.0060 | 2 | 2 |
| Matrix metalloproteinase-16 | Homo sapiens (human) | IC50 | 0.0080 | 2 | 2 |
| Matrix metalloproteinase-17 | Homo sapiens (human) | IC50 | 0.0034 | 1 | 1 |
| Matrix metalloproteinase-26 | Homo sapiens (human) | IC50 | 0.0170 | 2 | 2 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 0.6303 | 15 | 15 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | Ki | 0.0004 | 2 | 2 |
| Mcl-1 | Homo sapiens (human) | IC50 | 6.2272 | 2 | 3 |
| MecA | Staphylococcus aureus | IC50 | 710.0000 | 1 | 1 |
| melanocortin receptor 4 | Homo sapiens (human) | IC50 | 1.9970 | 1 | 1 |
| Methionine aminopeptidase 1 | Homo sapiens (human) | IC50 | 16.4667 | 3 | 3 |
| Methionine aminopeptidase 2 | Homo sapiens (human) | IC50 | 2.8325 | 4 | 4 |
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | IC50 | 6.3810 | 3 | 3 |
| Microtubule-associated protein tau | Homo sapiens (human) | IC50 | 0.4900 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3A | Homo sapiens (human) | IC50 | 42.9000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3A | Homo sapiens (human) | Ki | 8.8000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3B | Homo sapiens (human) | IC50 | 172.0000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3B | Homo sapiens (human) | Ki | 19.3000 | 1 | 1 |
| Mitochondrial 2-oxodicarboxylate carrier | Homo sapiens (human) | IC50 | 0.0110 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 2.6849 | 5 | 7 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 15.8289 | 2 | 9 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 21.0176 | 4 | 12 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | IC50 | 3.8742 | 1 | 2 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | IC50 | 0.5463 | 3 | 3 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | IC50 | 0.7000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | IC50 | 0.0170 | 8 | 8 |
| Monocarboxylate transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Monocarboxylate transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| Monoglyceride lipase | Rattus norvegicus (Norway rat) | IC50 | 0.0880 | 1 | 1 |
| MPI protein | Homo sapiens (human) | IC50 | 0.2905 | 2 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 2.1450 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.2400 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 0.8710 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 767.5000 | 2 | 2 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 250.3500 | 1 | 2 |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | Ki | 3.8250 | 2 | 4 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 114.3000 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 0.7535 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | IC50 | 0.8600 | 1 | 4 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 0.1815 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 1.0020 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 0.8600 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 0.3560 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 2.3565 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | IC50 | 0.8600 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 0.4995 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | IC50 | 0.6310 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | IC50 | 0.8600 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 0.0880 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.3345 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | IC50 | 0.8600 | 1 | 3 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | Ki | 0.2400 | 1 | 2 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 1.8060 | 4 | 5 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | Mus musculus (house mouse) | IC50 | 11.0000 | 1 | 1 |
| N-acylethanolamine-hydrolyzing acid amidase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | IC50 | 0.8100 | 1 | 1 |
| NAD-dependent protein deacetylase HST2 | Saccharomyces cerevisiae S288C | IC50 | 700.0000 | 1 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | IC50 | 400.2900 | 3 | 3 |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | IC50 | 14.4000 | 1 | 1 |
| NADPH oxidase 4 | Homo sapiens (human) | IC50 | 0.9400 | 1 | 2 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | 7.7500 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/USSR/90/1977(H1N1)) | IC50 | 63.7000 | 2 | 2 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 38.5845 | 6 | 11 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | Ki | 26.2333 | 1 | 3 |
| Neutrophil collagenase | Homo sapiens (human) | IC50 | 0.0054 | 2 | 2 |
| Neutrophil collagenase | Homo sapiens (human) | Ki | 0.0002 | 2 | 2 |
| neutrophil cytosol factor 1 | Homo sapiens (human) | IC50 | 0.3900 | 1 | 1 |
| Neutrophil cytosol factor 1 | Homo sapiens (human) | Ki | 125.0000 | 3 | 3 |
| Neutrophil elastase | Homo sapiens (human) | IC50 | 14.2927 | 3 | 3 |
| Neutrophil elastase | Homo sapiens (human) | Ki | 11.9000 | 1 | 1 |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | IC50 | 33.2000 | 2 | 2 |
| NT-3 growth factor receptor | Homo sapiens (human) | IC50 | 0.0049 | 7 | 7 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | IC50 | 5.0900 | 1 | 1 |
| nuclear receptor corepressor 2 isoform 2 | Homo sapiens (human) | IC50 | 39.8410 | 1 | 1 |
| Nuclear receptor subfamily 2 group C member 2 | Homo sapiens (human) | IC50 | 0.0090 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 0.1085 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 0.0889 | 1 | 1 |
| Oligo-1,6-glucosidase IMA1 | Saccharomyces cerevisiae S288C | IC50 | 530.0000 | 1 | 1 |
| P2Y purinoceptor 12 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Pancreatic triacylglycerol lipase | Sus scrofa (pig) | IC50 | 81.0000 | 3 | 5 |
| perilipin-1 | Homo sapiens (human) | IC50 | 2.5088 | 3 | 4 |
| perilipin-5 | Homo sapiens (human) | IC50 | 3.5897 | 5 | 7 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | Homo sapiens (human) | Ki | 0.3250 | 1 | 2 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | IC50 | 0.5660 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Ki | 22.0000 | 1 | 1 |
| peroxisome proliferator-activated receptor gamma isoform 2 | Homo sapiens (human) | IC50 | 39.8410 | 1 | 1 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | IC50 | 3.8000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 8.7950 | 2 | 2 |
| Phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 275.0000 | 1 | 1 |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | IC50 | 0.1110 | 1 | 1 |
| Phospholipase A-2-activating protein | Homo sapiens (human) | IC50 | 0.0110 | 1 | 1 |
| Phospholipase A2 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Phospholipase A2 | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Phospholipase A2, membrane associated | Homo sapiens (human) | IC50 | 3.5000 | 1 | 1 |
| phosphomannomutase 2 | Homo sapiens (human) | IC50 | 0.6720 | 1 | 1 |
| photoreceptor-specific nuclear receptor | Homo sapiens (human) | IC50 | 39.8410 | 1 | 1 |
| Plasma kallikrein | Homo sapiens (human) | Ki | 9.6000 | 1 | 1 |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | IC50 | 3.8000 | 1 | 1 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 71.0857 | 1 | 14 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 115.8522 | 8 | 9 |
| Polyphenol oxidase 2 | Agaricus bisporus | Ki | 0.0600 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 14.3138 | 11 | 13 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 9.6333 | 7 | 9 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | IC50 | 22.8571 | 3 | 7 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Ki | 1.6000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 21.3288 | 4 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 13.2100 | 2 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | Ki | 0.6000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | IC50 | 53.9611 | 4 | 9 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Rattus norvegicus (Norway rat) | IC50 | 0.2600 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 0.1085 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 0.0889 | 1 | 1 |
| Probable linoleate 9S-lipoxygenase 5 | Solanum tuberosum (potato) | IC50 | 43.0000 | 1 | 1 |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 0.6700 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | Ki | 9.3000 | 1 | 1 |
| procathepsin L isoform 1 preproprotein | Homo sapiens (human) | IC50 | 25.1129 | 2 | 2 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | Gallus gallus (chicken) | Ki | 20,000.0000 | 1 | 2 |
| Prolyl endopeptidase | Homo sapiens (human) | IC50 | 54.6600 | 2 | 5 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 170.7082 | 3 | 4 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 95.0000 | 2 | 2 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 1.0503 | 2 | 2 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 2 | 3 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 66.8740 | 5 | 6 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | IC50 | 11.3000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 0.0006 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 2 | 3 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0101 | 1 | 1 |
| Proteasome subunit beta type-5 | Homo sapiens (human) | IC50 | 6.7500 | 2 | 4 |
| Protein DBF4 homolog A | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Protein E6 | Human papillomavirus 16 | IC50 | 14.6667 | 1 | 3 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 9.3000 | 1 | 1 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C beta type | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 15.3560 | 3 | 3 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| protein Mdm4 isoform 1 | Homo sapiens (human) | IC50 | 3.5800 | 1 | 1 |
| Protein Rev | HIV-1 M:B_HXB2R | IC50 | 21.0000 | 1 | 1 |
| Protein Rev | HIV-1 M:B_HXB2R | IC50 | 21.0000 | 1 | 1 |
| Protein Tat | Human immunodeficiency virus type 1 (CLONE 12) | IC50 | 28.0000 | 1 | 1 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | IC50 | 0.1950 | 1 | 1 |
| Prothrombin | Homo sapiens (human) | IC50 | 14.5000 | 3 | 3 |
| Prothrombin | Bos taurus (cattle) | IC50 | 28.7500 | 1 | 4 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | IC50 | 39.2465 | 2 | 2 |
| Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | IC50 | 0.0072 | 7 | 7 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 7.5600 | 2 | 2 |
| putative polyprotein | | IC50 | 9.9185 | 2 | 4 |
| Pyruvate kinase | Staphylococcus aureus subsp. aureus MRSA252 | IC50 | 0.0600 | 1 | 1 |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | IC50 | 73.4200 | 1 | 3 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 7.6950 | 2 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 3.8272 | 1 | 4 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 3.2685 | 2 | 4 |
| Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | IC50 | 7.3000 | 1 | 2 |
| Renin | Homo sapiens (human) | IC50 | 0.9800 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | IC50 | 0.6700 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | Ki | 6.0000 | 2 | 3 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 8.4450 | 2 | 6 |
| Replicase polyprotein 1ab | Human coronavirus 229E | IC50 | 0.6700 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 7.4456 | 25 | 47 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 24.9287 | 5 | 15 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Ki | 7.4000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | Ki | 7.4000 | 1 | 1 |
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | IC50 | 11.6872 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 5.1000 | 2 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Homo sapiens (human) | IC50 | 27.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Mus musculus (house mouse) | IC50 | 27.0000 | 1 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | IC50 | 37.2500 | 2 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | Ki | 106.7000 | 1 | 1 |
| sentrin-specific protease 1 | Homo sapiens (human) | IC50 | 12.1225 | 4 | 4 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | IC50 | 7.5890 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase LMTK3 | Homo sapiens (human) | IC50 | 4.6530 | 1 | 1 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | IC50 | 5.8000 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | IC50 | 5.7300 | 1 | 1 |
| Serine/threonine-protein kinase Nek6 | Homo sapiens (human) | IC50 | 7.1150 | 2 | 2 |
| Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 2.2304 | 6 | 8 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | IC50 | 17.4933 | 5 | 6 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | IC50 | 314.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Short transient receptor potential channel 5 | Homo sapiens (human) | IC50 | 5.2000 | 1 | 2 |
| Sialidase | Clostridium perfringens | IC50 | 12.6175 | 6 | 8 |
| Sialidase | Clostridium perfringens | Ki | 4.2900 | 1 | 1 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 173.3333 | 1 | 3 |
| small ubiquitin-related modifier 2 isoform b precursor | Homo sapiens (human) | IC50 | 12.1450 | 2 | 2 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 2 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 2.7170 | 1 | 2 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 2.1590 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 2.3470 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 2.3280 | 1 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 3.3937 | 1 | 2 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 1.0000 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 1.8028 | 1 | 2 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 7,375.0000 | 2 | 4 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | Ki | 2,129.0758 | 1 | 4 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 2,125.0000 | 1 | 2 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | IC50 | 4.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 2 | Homo sapiens (human) | IC50 | 12.0000 | 2 | 2 |
| Solute carrier family 2, facilitated glucose transporter member 4 | Rattus norvegicus (Norway rat) | Ki | 16.0000 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 3.7550 | 2 | 2 |
| Solute carrier family 22 member 11 | Homo sapiens (human) | Ki | 235.5000 | 1 | 1 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Rattus norvegicus (Norway rat) | IC50 | 18.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | Ki | 5.7400 | 1 | 1 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | IC50 | 0.4100 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 5.4100 | 1 | 1 |
| Solute carrier family 22 member 8 | Mus musculus (house mouse) | IC50 | 32.9500 | 1 | 2 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 8.6000 | 1 | 1 |
| Sorbitol dehydrogenase | Homo sapiens (human) | IC50 | 106.3000 | 2 | 2 |
| Sortase A | Streptococcus mutans | IC50 | 27.2000 | 1 | 1 |
| Spermine oxidase | Homo sapiens (human) | Ki | 0.3250 | 1 | 2 |
| Spike glycoprotein | Betacoronavirus England 1 | IC50 | 0.6700 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | IC50 | 5.6000 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | IC50 | 0.6700 | 1 | 1 |
| Steroid hormone receptor ERR1 | Homo sapiens (human) | IC50 | 9.6400 | 1 | 1 |
| Stromelysin-1 | Homo sapiens (human) | IC50 | 0.5664 | 10 | 10 |
| Stromelysin-1 | Homo sapiens (human) | Ki | 0.0265 | 2 | 2 |
| Structural capsid protein | Human immunodeficiency virus 1 | IC50 | 0.0467 | 1 | 1 |
| Substance-K receptor | Cavia porcellus (domestic guinea pig) | IC50 | 58.5000 | 1 | 2 |
| Substance-K receptor | Homo sapiens (human) | IC50 | 2.5811 | 1 | 3 |
| Substance-K receptor | Homo sapiens (human) | Ki | 0.8606 | 1 | 3 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 58.5000 | 1 | 2 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | IC50 | 31.6000 | 3 | 3 |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | IC50 | 156.0000 | 2 | 2 |
| Sulfhydryl oxidase 1 | Homo sapiens (human) | IC50 | 5.4000 | 1 | 1 |
| SUMO-1 | Homo sapiens (human) | IC50 | 22.2500 | 2 | 2 |
| SUMO-activating enzyme subunit 1 | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Synaptojanin-1 | Homo sapiens (human) | IC50 | 15.9000 | 2 | 2 |
| Synaptojanin-2 | Homo sapiens (human) | IC50 | 10.0000 | 3 | 3 |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | IC50 | 97.6100 | 2 | 2 |
| TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 | Homo sapiens (human) | IC50 | 0.0087 | 3 | 3 |
| Thermolysin | Bacillus thermoproteolyticus | IC50 | 253.6667 | 2 | 3 |
| Thermolysin | Bacillus thermoproteolyticus | Ki | 214.0000 | 1 | 1 |
| Thiopurine S-methyltransferase | Homo sapiens (human) | IC50 | 1,288.2500 | 1 | 1 |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus (Norway rat) | IC50 | 185.0000 | 1 | 1 |
| Thioredoxin reductase 2, mitochondrial | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Thioredoxin reductase 2, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 132.0000 | 1 | 1 |
| Thioredoxin reductase 3 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 56.0000 | 1 | 4 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 3.0870 | 1 | 1 |
| Tissue alpha-L-fucosidase | Bos taurus (cattle) | IC50 | 32.0000 | 1 | 1 |
| Tissue-type plasminogen activator | Homo sapiens (human) | IC50 | 3.8000 | 1 | 1 |
| Toxin B | Clostridioides difficile | IC50 | 0.0172 | 1 | 1 |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | IC50 | 5.2900 | 2 | 2 |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | IC50 | 0.8800 | 1 | 1 |
| Transcription factor 4 | Homo sapiens (human) | IC50 | 0.8000 | 1 | 1 |
| Transcription factor 7-like 2 | Homo sapiens (human) | Ki | 46.4167 | 6 | 6 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | IC50 | 13.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | IC50 | 13.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | IC50 | 0.1600 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | IC50 | 0.1600 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | IC50 | 2.6000 | 2 | 2 |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 1.5000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 3 | Homo sapiens (human) | IC50 | 66.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 0.6700 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | IC50 | 76.7500 | 2 | 2 |
| Trypanothione reductase | Trypanosoma cruzi | Ki | 2.0000 | 1 | 1 |
| Trypsin-1 | Homo sapiens (human) | IC50 | 339.7000 | 2 | 3 |
| Trypsin-2 | Homo sapiens (human) | IC50 | 339.7000 | 2 | 3 |
| Trypsin-3 | Homo sapiens (human) | IC50 | 339.7000 | 2 | 3 |
| Tyrosinase | Homo sapiens (human) | IC50 | 29.7417 | 5 | 6 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 2.4358 | 1 | 5 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | IC50 | 0.1120 | 1 | 1 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | IC50 | 0.0400 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | IC50 | 0.3490 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 5.2434 | 4 | 7 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | IC50 | 0.9600 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | IC50 | 16.3333 | 2 | 3 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | IC50 | 3.3000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Ki | 5.0473 | 1 | 3 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 19.7800 | 8 | 10 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | Ki | 9.6000 | 1 | 1 |
| tyrosine-protein phosphatase non-receptor type 22 isoform 1 | Homo sapiens (human) | IC50 | 1.2950 | 2 | 2 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | IC50 | 67.0800 | 3 | 3 |
| tyrosyl-DNA phosphodiesterase 2 | Homo sapiens (human) | IC50 | 128.3320 | 1 | 1 |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | IC50 | 8.4030 | 2 | 3 |
| UDP-glucose 4-epimerase | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 5.7000 | 2 | 2 |
| Undecaprenyl-diphosphatase | Escherichia coli K-12 | IC50 | 5.6000 | 1 | 1 |
| Urease subunit alpha | Helicobacter pylori 26695 | IC50 | 55.7862 | 7 | 8 |
| Urease subunit alpha | Helicobacter pylori 26695 | Ki | 4.7830 | 2 | 2 |
| Urease subunit beta | Helicobacter pylori 26695 | IC50 | 55.7862 | 7 | 8 |
| Urease subunit beta | Helicobacter pylori 26695 | Ki | 4.7830 | 2 | 2 |
| Urokinase-type plasminogen activator | Homo sapiens (human) | IC50 | 21.8167 | 3 | 6 |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | IC50 | 3.8000 | 1 | 1 |
| Valosin-containing protein | Homo sapiens (human) | IC50 | 27.7440 | 2 | 2 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 0.9800 | 3 | 3 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Vasopressin V2 receptor | Homo sapiens (human) | IC50 | 20.3282 | 3 | 6 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 35.5667 | 2 | 3 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 6.8088 | 4 | 8 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | Ki | 1.2000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | Ki | 0.2800 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 26S proteasome regulatory subunit 6B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| AarF domain-containing protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Actin-related protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Actin-related protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Kd | 0.4200 | 1 | 1 |
| Activin receptor type-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activin receptor type-1B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activin receptor type-2B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenine phosphoribosyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenosine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ADP/ATP translocase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ADP/ATP translocase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Albumin | Homo sapiens (human) | Kd | 12.0000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 31.5000 | 1 | 2 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 31.5000 | 1 | 2 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 31.5000 | 1 | 2 |
| Amyloid-beta precursor protein | Homo sapiens (human) | EC50 | 8.4100 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 44.0350 | 1 | 2 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent 6-phosphofructokinase, platelet type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX3X | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX42 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DHX30 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Kd | 6.9201 | 1 | 2 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Kd | 6.7000 | 1 | 1 |
| Atypical kinase COQ8A, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Aurora kinase A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| bcl-2-like protein 11 isoform 1 | Homo sapiens (human) | EC50 | 350.0000 | 1 | 1 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Beta-galactosidase | Escherichia coli | EC50 | 31.5000 | 1 | 2 |
| Beta-lactamase | Klebsiella pneumoniae | Kd | 0.8500 | 1 | 1 |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | Kd | 12.0000 | 1 | 1 |
| BMP-2-inducible protein kinase | Homo sapiens (human) | Kd | 15.0019 | 2 | 2 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Bone morphogenetic protein receptor type-1B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | EC50 | 0.1953 | 3 | 3 |
| calcineurin A1, putative | Candida dubliniensis CD36 | EC50 | 180.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Carbonic anhydrase 2 | Bos taurus (cattle) | Kd | 5.8800 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Kd | 5.5500 | 1 | 1 |
| Casein kinase I isoform alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform delta | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | Homo sapiens (human) | EC50 | 350.0000 | 1 | 1 |
| Chain A, Gyrase | Escherichia coli | Kd | 1.2000 | 1 | 1 |
| Chain A, Repressor | Stenotrophomonas maltophilia | Kd | 0.6300 | 1 | 1 |
| Chain A, TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR | Mycolicibacterium smegmatis | Kd | 0.0790 | 1 | 1 |
| Chain A, Transcriptional regulator qacR | Staphylococcus aureus | Kd | 38.5000 | 1 | 4 |
| Chain A, Transthyretin | Homo sapiens (human) | Kd | 2.1000 | 1 | 5 |
| Chain B, Transthyretin | Homo sapiens (human) | Kd | 2.1000 | 1 | 2 |
| Chain H, ALPHA-THROMBIN | Homo sapiens (human) | Kd | 530.0000 | 1 | 1 |
| Chromodomain-helicase-DNA-binding protein 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| citrate synthase 2, partial | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 9,958.1500 | 2 | 2 |
| Citron Rho-interacting kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Cyclin-dependent kinase-like 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-G-associated kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cysteine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | Kd | 25.6000 | 1 | 1 |
| Cytochrome c1, heme protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cytochrome P450 1A1 | Homo sapiens (human) | EC50 | 8.8000 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | EC50 | 1.1000 | 1 | 1 |
| dCTP pyrophosphatase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| delta-type opioid receptor | Homo sapiens (human) | EC50 | 52.1537 | 2 | 3 |
| Delta(24)-sterol reductase | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Deoxycytidine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| DNA gyrase subunit B | Escherichia coli K-12 | Kd | 0.0175 | 2 | 2 |
| DNA replication licensing factor MCM4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DnaJ homolog subfamily A member 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity testis-specific protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dynamin-like 120 kDa protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| EKC/KEOPS complex subunit TP53RK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Electron transfer flavoprotein subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Elongation factor Tu, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | 1 | 2 |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | 1 | 2 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Exosome RNA helicase MTR4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ferrochelatase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Focal adhesion kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Free fatty acid receptor 1 | Homo sapiens (human) | EC50 | 6.7278 | 3 | 3 |
| Free fatty acid receptor 4 | Homo sapiens (human) | EC50 | 7.5858 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | EC50 | 9.9133 | 2 | 6 |
| G-protein coupled receptor 84 | Homo sapiens (human) | EC50 | 23.4520 | 18 | 20 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | Kd | 4.1000 | 2 | 2 |
| General transcription and DNA repair factor IIH helicase subunit XPD | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Genome polyprotein | Zika virus | EC50 | 24.8000 | 1 | 1 |
| Glycine--tRNA ligase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen phosphorylase, brain form | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 37.1650 | 1 | 2 |
| GTP-binding nuclear protein Ran | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| heat shock protein 90 | Candida albicans | EC50 | 75.9632 | 3 | 4 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | EC50 | 700.0000 | 1 | 1 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | Kd | 500.0000 | 1 | 1 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | EC50 | 700.0000 | 1 | 1 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | Kd | 500.0000 | 1 | 1 |
| Heme oxygenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | Homo sapiens (human) | Kd | 5.3000 | 1 | 2 |
| hexokinase HKDC1 | Homo sapiens (human) | EC50 | 38.8000 | 1 | 1 |
| hexokinase-1 isoform HKI | Homo sapiens (human) | EC50 | 41.9000 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 0.0020 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | EC50 | 11.1000 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Insulin receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| insulin-degrading enzyme isoform 1 | Homo sapiens (human) | EC50 | 54.7240 | 2 | 4 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Integrin-linked protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interstitial collagenase | Homo sapiens (human) | Kd | 51.8000 | 1 | 1 |
| Isoleucine--tRNA ligase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| LAP4 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 39.1995 | 2 | 4 |
| LIM domain kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| LIM domain kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Long-chain-fatty-acid--CoA ligase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Major pollen allergen Bet v 1-A | Betula pendula (European white birch) | Kd | 140.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| melanocortin receptor 4 | Homo sapiens (human) | EC50 | 89.1880 | 1 | 2 |
| Membrane-associated progesterone receptor component 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| MEP2 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 100,277.8065 | 3 | 4 |
| Metallo-beta-lactamase type 2 | Klebsiella pneumoniae | Kd | 11.0000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3A | Homo sapiens (human) | Kd | 7.5000 | 1 | 1 |
| Microtubule-associated proteins 1A/1B light chain 3B | Homo sapiens (human) | Kd | 17.4000 | 1 | 1 |
| Midasin | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Misshapen-like kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| mu opioid receptor, partial | Homo sapiens (human) | EC50 | 32.0000 | 1 | 2 |
| mu-type opioid receptor isoform MOR-1 | Homo sapiens (human) | EC50 | 92.4610 | 1 | 1 |
| Multifunctional protein ADE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin light chain kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin-14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| neuropeptide Y receptor type 1 | Homo sapiens (human) | EC50 | 9.7960 | 1 | 1 |
| neuropeptide Y receptor type 2 | Homo sapiens (human) | EC50 | 11.8100 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | Kd | 1.4860 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| NPYLR7B | Aedes aegypti (yellow fever mosquito) | EC50 | 20.0000 | 1 | 2 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 39.8000 | 1 | 1 |
| Nucleolar GTP-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Nucleoside diphosphate kinase B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Obg-like ATPase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | EC50 | 17.2500 | 1 | 2 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 23.5750 | 3 | 4 |
| Phenylalanine--tRNA ligase beta subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylethanolamine-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| POsterior Segregation | Caenorhabditis elegans | EC50 | 45.4450 | 1 | 1 |
| Probable ATP-dependent RNA helicase DDX6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | EC50 | 44.0350 | 1 | 2 |
| Protease | Human immunodeficiency virus 1 | Kd | 0.5770 | 1 | 1 |
| Protein argonaute-2 | Homo sapiens (human) | Kd | 17.0000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C beta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C delta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C iota type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C theta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein Rev | HIV-1 M:B_HXB2R | Kd | 4.1100 | 1 | 1 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Prothrombin | Homo sapiens (human) | Kd | 0.0387 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Putative heat shock protein HSP 90-beta 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Putative nucleoside diphosphate kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Pyridoxal kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Rab-like protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-27A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-6A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| recombinase A | Mycobacterium tuberculosis H37Rv | EC50 | 3.6100 | 2 | 4 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 57.1567 | 2 | 3 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 44.0350 | 1 | 2 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 57.1567 | 2 | 3 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 14.0512 | 4 | 8 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 35.8160 | 3 | 5 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Kd | 13.9500 | 4 | 6 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RNA cytidine acetyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RPL19A | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 11.8900 | 1 | 1 |
| S-adenosylmethionine synthase isoform type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Septin-9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 24 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 38 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ICK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | Kd | 15.0125 | 2 | 2 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Signal recognition particle receptor subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | EC50 | 19.0950 | 1 | 1 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 44.0350 | 1 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 44.0350 | 1 | 2 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| STE20-related kinase adapter protein alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 22.1643 | 2 | 7 |
| Structural maintenance of chromosomes protein 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Structural maintenance of chromosomes protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TGF-beta receptor type-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TGF-beta receptor type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Thyroid hormone receptor-associated protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 1.3050 | 2 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | Mus musculus (house mouse) | EC50 | 1.3200 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | EC50 | 2.0500 | 2 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | EC50 | 1.3000 | 2 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | Rattus norvegicus (Norway rat) | EC50 | 51.2200 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | EC50 | 1.7000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | EC50 | 1.7000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 3 | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | EC50 | 5.1000 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 44.0350 | 1 | 2 |
| Transthyretin | Homo sapiens (human) | EC50 | 8.6000 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | Kd | 144.0000 | 1 | 1 |
| Tubulin alpha-1A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-1B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-1C chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-3C chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-3E chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-4A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-1 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-2A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-2B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-3 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-4A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-4B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-6 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-8 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tumor necrosis factor | Homo sapiens (human) | Kd | 0.2000 | 1 | 1 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | EC50 | 167.5000 | 1 | 2 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Uncharacterized aarF domain-containing protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Uncharacterized protein FLJ45252 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Wee1-like protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Zinc finger protein mex-5 | Caenorhabditis elegans | EC50 | 19.0950 | 1 | 1 |